WO2022123016A1 - Substrat cosmétique d'origine naturelle - Google Patents
Substrat cosmétique d'origine naturelle Download PDFInfo
- Publication number
- WO2022123016A1 WO2022123016A1 PCT/EP2021/085209 EP2021085209W WO2022123016A1 WO 2022123016 A1 WO2022123016 A1 WO 2022123016A1 EP 2021085209 W EP2021085209 W EP 2021085209W WO 2022123016 A1 WO2022123016 A1 WO 2022123016A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polysaccharides
- notably
- substrate
- water
- cosmetic
- Prior art date
Links
- 239000000758 substrate Substances 0.000 title claims abstract description 183
- 239000002537 cosmetic Substances 0.000 title claims abstract description 69
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 152
- 239000005017 polysaccharide Substances 0.000 claims abstract description 152
- 238000000034 method Methods 0.000 claims abstract description 39
- 230000008569 process Effects 0.000 claims abstract description 32
- 239000000463 material Substances 0.000 claims abstract description 28
- 102000011782 Keratins Human genes 0.000 claims abstract description 20
- 108010076876 Keratins Proteins 0.000 claims abstract description 20
- 150000004676 glycans Chemical class 0.000 claims abstract 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 105
- 239000000203 mixture Substances 0.000 claims description 87
- 241000196324 Embryophyta Species 0.000 claims description 50
- 239000002609 medium Substances 0.000 claims description 46
- 229920002472 Starch Polymers 0.000 claims description 41
- 235000019698 starch Nutrition 0.000 claims description 40
- 239000013543 active substance Substances 0.000 claims description 39
- 239000008107 starch Substances 0.000 claims description 32
- 238000004108 freeze drying Methods 0.000 claims description 31
- 239000002904 solvent Substances 0.000 claims description 27
- 150000001875 compounds Chemical class 0.000 claims description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 24
- 239000000017 hydrogel Substances 0.000 claims description 24
- 229920000642 polymer Polymers 0.000 claims description 23
- 229920002581 Glucomannan Polymers 0.000 claims description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 21
- 239000008346 aqueous phase Substances 0.000 claims description 21
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 21
- 239000012634 fragment Substances 0.000 claims description 19
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 18
- 229940046240 glucomannan Drugs 0.000 claims description 18
- 229960001031 glucose Drugs 0.000 claims description 17
- 229920000869 Homopolysaccharide Polymers 0.000 claims description 16
- 229920002752 Konjac Polymers 0.000 claims description 16
- 229920002678 cellulose Polymers 0.000 claims description 16
- -1 xilogel Polymers 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 229920001525 carrageenan Polymers 0.000 claims description 15
- 235000010980 cellulose Nutrition 0.000 claims description 15
- 239000008103 glucose Substances 0.000 claims description 15
- 239000000252 konjac Substances 0.000 claims description 15
- 229920001817 Agar Polymers 0.000 claims description 13
- 229920001661 Chitosan Polymers 0.000 claims description 13
- 229920000926 Galactomannan Polymers 0.000 claims description 13
- 238000007710 freezing Methods 0.000 claims description 13
- 230000008014 freezing Effects 0.000 claims description 13
- 239000000654 additive Substances 0.000 claims description 12
- 235000010419 agar Nutrition 0.000 claims description 12
- 239000001913 cellulose Substances 0.000 claims description 12
- 229920001285 xanthan gum Polymers 0.000 claims description 12
- 239000006227 byproduct Substances 0.000 claims description 11
- 235000010418 carrageenan Nutrition 0.000 claims description 11
- 230000018044 dehydration Effects 0.000 claims description 11
- 238000006297 dehydration reaction Methods 0.000 claims description 11
- 241000195493 Cryptophyta Species 0.000 claims description 10
- 235000013399 edible fruits Nutrition 0.000 claims description 10
- 239000004615 ingredient Substances 0.000 claims description 10
- 235000010420 locust bean gum Nutrition 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 229920000856 Amylose Polymers 0.000 claims description 9
- 229920000161 Locust bean gum Polymers 0.000 claims description 9
- 229920001218 Pullulan Polymers 0.000 claims description 9
- 239000004373 Pullulan Substances 0.000 claims description 9
- 239000000490 cosmetic additive Substances 0.000 claims description 9
- 239000000711 locust bean gum Substances 0.000 claims description 9
- 235000019423 pullulan Nutrition 0.000 claims description 9
- 235000013311 vegetables Nutrition 0.000 claims description 9
- 229920002907 Guar gum Polymers 0.000 claims description 8
- 239000008272 agar Substances 0.000 claims description 8
- 229940023476 agar Drugs 0.000 claims description 8
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 8
- 239000012736 aqueous medium Substances 0.000 claims description 8
- 239000006185 dispersion Substances 0.000 claims description 8
- 235000010417 guar gum Nutrition 0.000 claims description 8
- 239000000665 guar gum Substances 0.000 claims description 8
- 229960002154 guar gum Drugs 0.000 claims description 8
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000003755 preservative agent Substances 0.000 claims description 7
- 238000000859 sublimation Methods 0.000 claims description 7
- 230000008022 sublimation Effects 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- 239000004365 Protease Substances 0.000 claims description 6
- 238000010382 chemical cross-linking Methods 0.000 claims description 6
- 239000003431 cross linking reagent Substances 0.000 claims description 6
- 229940088598 enzyme Drugs 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 239000003205 fragrance Substances 0.000 claims description 6
- 150000002402 hexoses Chemical class 0.000 claims description 6
- 235000019823 konjac gum Nutrition 0.000 claims description 6
- 230000003020 moisturizing effect Effects 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 230000002378 acidificating effect Effects 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 235000013339 cereals Nutrition 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 4
- 229920002148 Gellan gum Polymers 0.000 claims description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- 241001558929 Sclerotium <basidiomycota> Species 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- 235000001014 amino acid Nutrition 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 4
- 238000004040 coloring Methods 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- 150000002334 glycols Chemical class 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 238000007493 shaping process Methods 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 3
- 240000002900 Arthrospira platensis Species 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 3
- 150000000994 L-ascorbates Chemical class 0.000 claims description 3
- 108090001060 Lipase Proteins 0.000 claims description 3
- 239000004367 Lipase Substances 0.000 claims description 3
- 102000004882 Lipase Human genes 0.000 claims description 3
- 108010038807 Oligopeptides Proteins 0.000 claims description 3
- 102000015636 Oligopeptides Human genes 0.000 claims description 3
- 108090000526 Papain Proteins 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 102000035195 Peptidases Human genes 0.000 claims description 3
- 240000003946 Saponaria officinalis Species 0.000 claims description 3
- 206010040844 Skin exfoliation Diseases 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- 150000007514 bases Chemical class 0.000 claims description 3
- 239000003876 biosurfactant Substances 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 3
- 239000002738 chelating agent Substances 0.000 claims description 3
- 235000018417 cysteine Nutrition 0.000 claims description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
- 239000003974 emollient agent Substances 0.000 claims description 3
- 229920003063 hydroxymethyl cellulose Polymers 0.000 claims description 3
- 229940031574 hydroxymethyl cellulose Drugs 0.000 claims description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 3
- 229960000367 inositol Drugs 0.000 claims description 3
- 235000019421 lipase Nutrition 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 238000003801 milling Methods 0.000 claims description 3
- 229940055729 papain Drugs 0.000 claims description 3
- 235000019834 papain Nutrition 0.000 claims description 3
- 150000002972 pentoses Chemical class 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 3
- 239000003009 skin protective agent Substances 0.000 claims description 3
- 229940082787 spirulina Drugs 0.000 claims description 3
- 150000005846 sugar alcohols Polymers 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 229940074410 trehalose Drugs 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 239000000341 volatile oil Substances 0.000 claims description 3
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 208000035484 Cellulite Diseases 0.000 claims description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
- 229920002558 Curdlan Polymers 0.000 claims description 2
- 239000001879 Curdlan Substances 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims description 2
- 229920001543 Laminarin Polymers 0.000 claims description 2
- 239000005717 Laminarin Substances 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- 206010049752 Peau d'orange Diseases 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 229930003779 Vitamin B12 Natural products 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 239000011324 bead Substances 0.000 claims description 2
- 235000021028 berry Nutrition 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 235000021466 carotenoid Nutrition 0.000 claims description 2
- 150000001747 carotenoids Chemical class 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 229940045110 chitosan Drugs 0.000 claims description 2
- 230000000959 cryoprotective effect Effects 0.000 claims description 2
- 235000019316 curdlan Nutrition 0.000 claims description 2
- 229940078035 curdlan Drugs 0.000 claims description 2
- 235000013804 distarch phosphate Nutrition 0.000 claims description 2
- 239000001245 distarch phosphate Substances 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 235000010492 gellan gum Nutrition 0.000 claims description 2
- 239000000216 gellan gum Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000000416 hydrocolloid Substances 0.000 claims description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 2
- 235000010449 maltitol Nutrition 0.000 claims description 2
- 239000000845 maltitol Substances 0.000 claims description 2
- 229940035436 maltitol Drugs 0.000 claims description 2
- 229960002160 maltose Drugs 0.000 claims description 2
- 238000000465 moulding Methods 0.000 claims description 2
- 229940055726 pantothenic acid Drugs 0.000 claims description 2
- 235000019161 pantothenic acid Nutrition 0.000 claims description 2
- 239000011713 pantothenic acid Substances 0.000 claims description 2
- 239000011049 pearl Substances 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims description 2
- 235000008160 pyridoxine Nutrition 0.000 claims description 2
- 239000011677 pyridoxine Substances 0.000 claims description 2
- 239000002151 riboflavin Substances 0.000 claims description 2
- 235000019192 riboflavin Nutrition 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 238000005096 rolling process Methods 0.000 claims description 2
- 229960004793 sucrose Drugs 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- 235000019163 vitamin B12 Nutrition 0.000 claims description 2
- 239000011715 vitamin B12 Substances 0.000 claims description 2
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 239000011710 vitamin D Substances 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 235000019168 vitamin K Nutrition 0.000 claims description 2
- 239000011712 vitamin K Substances 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- 150000004804 polysaccharides Chemical class 0.000 description 130
- 210000003491 skin Anatomy 0.000 description 49
- 239000000499 gel Substances 0.000 description 34
- 239000000126 substance Substances 0.000 description 29
- 239000000047 product Substances 0.000 description 28
- 229920000742 Cotton Polymers 0.000 description 27
- 230000000694 effects Effects 0.000 description 24
- 229920001277 pectin Polymers 0.000 description 24
- 235000010987 pectin Nutrition 0.000 description 23
- 239000001814 pectin Substances 0.000 description 23
- 239000002253 acid Substances 0.000 description 19
- 235000001727 glucose Nutrition 0.000 description 16
- 229920000858 Cyclodextrin Polymers 0.000 description 15
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 13
- 229920002101 Chitin Polymers 0.000 description 13
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 13
- 229920002674 hyaluronan Polymers 0.000 description 13
- 229960003160 hyaluronic acid Drugs 0.000 description 13
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 12
- 229920002683 Glycosaminoglycan Polymers 0.000 description 12
- 229920000084 Gum arabic Polymers 0.000 description 12
- 235000010489 acacia gum Nutrition 0.000 description 12
- 238000000855 fermentation Methods 0.000 description 12
- 230000004151 fermentation Effects 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 235000000346 sugar Nutrition 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical group OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 11
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 11
- 229920002307 Dextran Polymers 0.000 description 11
- 229920002670 Fructan Polymers 0.000 description 11
- 239000000205 acacia gum Substances 0.000 description 11
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 11
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 11
- 150000001720 carbohydrates Chemical class 0.000 description 11
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 11
- 230000001953 sensory effect Effects 0.000 description 11
- 244000247812 Amorphophallus rivieri Species 0.000 description 10
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 229920000945 Amylopectin Polymers 0.000 description 9
- 229920001287 Chondroitin sulfate Polymers 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 9
- 229960002086 dextran Drugs 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 9
- 210000004209 hair Anatomy 0.000 description 9
- 235000010485 konjac Nutrition 0.000 description 9
- 229920000728 polyester Polymers 0.000 description 9
- 238000001542 size-exclusion chromatography Methods 0.000 description 9
- 150000008163 sugars Chemical class 0.000 description 9
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 8
- 229920002261 Corn starch Polymers 0.000 description 8
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 8
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 8
- 229940059329 chondroitin sulfate Drugs 0.000 description 8
- 239000008120 corn starch Substances 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 244000144927 Aloe barbadensis Species 0.000 description 7
- 235000002961 Aloe barbadensis Nutrition 0.000 description 7
- 241000934878 Sterculia Species 0.000 description 7
- 235000011399 aloe vera Nutrition 0.000 description 7
- 239000000975 dye Substances 0.000 description 7
- 230000032050 esterification Effects 0.000 description 7
- 238000005886 esterification reaction Methods 0.000 description 7
- 229930182830 galactose Natural products 0.000 description 7
- 229960003082 galactose Drugs 0.000 description 7
- 229940097043 glucuronic acid Drugs 0.000 description 7
- 229930182470 glycoside Natural products 0.000 description 7
- 230000000813 microbial effect Effects 0.000 description 7
- 238000000569 multi-angle light scattering Methods 0.000 description 7
- 239000000049 pigment Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 241000894007 species Species 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 241000416162 Astragalus gummifer Species 0.000 description 6
- 229930182476 C-glycoside Natural products 0.000 description 6
- 150000000700 C-glycosides Chemical class 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
- 229920001503 Glucan Polymers 0.000 description 6
- 229920000569 Gum karaya Polymers 0.000 description 6
- 229920001202 Inulin Polymers 0.000 description 6
- 240000005561 Musa balbisiana Species 0.000 description 6
- 229920002305 Schizophyllan Polymers 0.000 description 6
- 229920001615 Tragacanth Polymers 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 125000002091 cationic group Chemical group 0.000 description 6
- 239000003610 charcoal Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000000470 constituent Substances 0.000 description 6
- 229940097362 cyclodextrins Drugs 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 235000010494 karaya gum Nutrition 0.000 description 6
- 239000000231 karaya gum Substances 0.000 description 6
- 229940039371 karaya gum Drugs 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- 235000010491 tara gum Nutrition 0.000 description 6
- 239000000213 tara gum Substances 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 229920000189 Arabinogalactan Polymers 0.000 description 5
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 229920002971 Heparan sulfate Polymers 0.000 description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 5
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 5
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 5
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 5
- 241000206572 Rhodophyta Species 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 235000019312 arabinogalactan Nutrition 0.000 description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 5
- 229920000617 arabinoxylan Polymers 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 210000000845 cartilage Anatomy 0.000 description 5
- 238000004132 cross linking Methods 0.000 description 5
- 229960000633 dextran sulfate Drugs 0.000 description 5
- 150000002016 disaccharides Chemical group 0.000 description 5
- 229960002897 heparin Drugs 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 210000004400 mucous membrane Anatomy 0.000 description 5
- 229930014626 natural product Natural products 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000006150 trypticase soy agar Substances 0.000 description 5
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 4
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 4
- 239000001904 Arabinogalactan Substances 0.000 description 4
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 4
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 4
- 240000008886 Ceratonia siliqua Species 0.000 description 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 4
- 241000206672 Gelidium Species 0.000 description 4
- 240000008415 Lactuca sativa Species 0.000 description 4
- 235000003228 Lactuca sativa Nutrition 0.000 description 4
- 240000007472 Leucaena leucocephala Species 0.000 description 4
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 229960005305 adenosine Drugs 0.000 description 4
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 4
- 235000021302 avocado oil Nutrition 0.000 description 4
- 239000008163 avocado oil Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000003592 biomimetic effect Effects 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 210000004761 scalp Anatomy 0.000 description 4
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 3
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 3
- 240000001432 Calendula officinalis Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 235000005940 Centaurea cyanus Nutrition 0.000 description 3
- 240000004385 Centaurea cyanus Species 0.000 description 3
- 241000238424 Crustacea Species 0.000 description 3
- 244000303965 Cyamopsis psoralioides Species 0.000 description 3
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- 229920000045 Dermatan sulfate Polymers 0.000 description 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 3
- 240000003183 Manihot esculenta Species 0.000 description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 229920004482 WACKER® Polymers 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 108010054251 arabinogalactan proteins Proteins 0.000 description 3
- 150000004783 arabinoxylans Chemical class 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000006196 deacetylation Effects 0.000 description 3
- 238000003381 deacetylation reaction Methods 0.000 description 3
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 3
- 229940051593 dermatan sulfate Drugs 0.000 description 3
- 239000008121 dextrose Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 210000004709 eyebrow Anatomy 0.000 description 3
- 210000000720 eyelash Anatomy 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 210000000245 forearm Anatomy 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- IAJILQKETJEXLJ-LECHCGJUSA-N iduronic acid Chemical compound O=C[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-LECHCGJUSA-N 0.000 description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 3
- 229940029339 inulin Drugs 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000002906 microbiologic effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 239000001974 tryptic soy broth Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 229920001221 xylan Polymers 0.000 description 3
- 150000004823 xylans Chemical class 0.000 description 3
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- KOGFZZYPPGQZFZ-QVAPDBTGSA-N (2s,3r,4s,5r)-2-(2-hydroxypropyl)oxane-3,4,5-triol Chemical compound CC(O)C[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O KOGFZZYPPGQZFZ-QVAPDBTGSA-N 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 241000186063 Arthrobacter Species 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 2
- 235000005881 Calendula officinalis Nutrition 0.000 description 2
- 241000238366 Cephalopoda Species 0.000 description 2
- 235000007542 Cichorium intybus Nutrition 0.000 description 2
- 244000298479 Cichorium intybus Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 125000000333 D-xylopyranosyl group Chemical group [H]O[C@]1([H])C([H])([H])OC([H])(*)[C@]([H])(O[H])[C@@]1([H])O[H] 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 235000017367 Guainella Nutrition 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 244000308760 Helichrysum petiolatum Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 235000010254 Jasminum officinale Nutrition 0.000 description 2
- 240000005385 Jasminum sambac Species 0.000 description 2
- 102100034867 Kallikrein-7 Human genes 0.000 description 2
- 229920000288 Keratan sulfate Polymers 0.000 description 2
- 244000165082 Lavanda vera Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 229920000057 Mannan Polymers 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 241001134446 Niveas Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 2
- 241001494501 Prosopis <angiosperm> Species 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical group CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 235000011402 Rosa x damascena Nutrition 0.000 description 2
- 240000004978 Rosa x damascena Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 240000001058 Sterculia urens Species 0.000 description 2
- 235000015125 Sterculia urens Nutrition 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 2
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 230000021736 acetylation Effects 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 229920001284 acidic polysaccharide Polymers 0.000 description 2
- 150000004805 acidic polysaccharides Chemical class 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 229920001586 anionic polysaccharide Polymers 0.000 description 2
- 150000004836 anionic polysaccharides Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- DGQLVPJVXFOQEV-JNVSTXMASA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-JNVSTXMASA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000008876 conformational transition Effects 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000002577 cryoprotective agent Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 238000001825 field-flow fractionation Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 235000013980 iron oxide Nutrition 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 2
- LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 2
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000008247 solid mixture Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000001370 static light scattering Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 229940035936 ubiquinone Drugs 0.000 description 2
- 235000013799 ultramarine blue Nutrition 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- OFVBXCOYANJMRT-UHFFFAOYSA-N (1-hydroxy-2-methylpropan-2-yl)urea Chemical compound OCC(C)(C)NC(N)=O OFVBXCOYANJMRT-UHFFFAOYSA-N 0.000 description 1
- PURMPUDWXOWORS-SKNVOMKLSA-N (2r,3s,4s,5r)-2,3,4-trihydroxy-6-oxo-5-sulfooxyhexanoic acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@@H](OS(O)(=O)=O)C=O PURMPUDWXOWORS-SKNVOMKLSA-N 0.000 description 1
- WZYRMLAWNVOIEX-MOJAZDJTSA-N (2s)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyacetaldehyde Chemical group O=C[C@@H](O)[C@@H]1OC[C@H](O)[C@H]1O WZYRMLAWNVOIEX-MOJAZDJTSA-N 0.000 description 1
- QGGOCWIJGWDKHC-FSIIMWSLSA-N (2s,3s,4r,5r)-2,4,5-trihydroxy-3-methoxy-6-oxohexanoic acid Chemical compound OC(=O)[C@@H](O)[C@@H](OC)[C@H](O)[C@@H](O)C=O QGGOCWIJGWDKHC-FSIIMWSLSA-N 0.000 description 1
- JIMKNCCELIMQPR-UHFFFAOYSA-N (7,7-dimethyl-2-methylidene-3-oxo-4-bicyclo[2.2.1]heptanyl)methanesulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)C(=C)C1C2(C)C JIMKNCCELIMQPR-UHFFFAOYSA-N 0.000 description 1
- GRHQBTVCBZRVCM-UHFFFAOYSA-N 1,1,3,3-tetrakis(2-hydroxyethyl)urea Chemical compound OCCN(CCO)C(=O)N(CCO)CCO GRHQBTVCBZRVCM-UHFFFAOYSA-N 0.000 description 1
- OSPRSYHXEUOSQA-UHFFFAOYSA-N 1,1-bis(2-hydroxyethyl)-3,3-dimethylurea Chemical compound CN(C)C(=O)N(CCO)CCO OSPRSYHXEUOSQA-UHFFFAOYSA-N 0.000 description 1
- GBPMHVWWNARLJZ-UHFFFAOYSA-N 1,1-bis(2-hydroxyethyl)-3-propylurea Chemical compound CCCNC(=O)N(CCO)CCO GBPMHVWWNARLJZ-UHFFFAOYSA-N 0.000 description 1
- BQMXKMPREFOYHS-UHFFFAOYSA-N 1,1-bis(2-hydroxyethyl)urea Chemical compound OCCN(C(=O)N)CCO BQMXKMPREFOYHS-UHFFFAOYSA-N 0.000 description 1
- ZGLXBKOIZOVYND-UHFFFAOYSA-N 1,1-bis(2-hydroxypropyl)urea Chemical compound CC(O)CN(C(N)=O)CC(C)O ZGLXBKOIZOVYND-UHFFFAOYSA-N 0.000 description 1
- KSYGJAFGQWTAFW-UHFFFAOYSA-N 1,3-bis(2-hydroxyethyl)urea Chemical compound OCCNC(=O)NCCO KSYGJAFGQWTAFW-UHFFFAOYSA-N 0.000 description 1
- UBZFJRDOTBGVAY-UHFFFAOYSA-N 1,3-bis(2-hydroxypropyl)urea Chemical compound CC(O)CNC(=O)NCC(C)O UBZFJRDOTBGVAY-UHFFFAOYSA-N 0.000 description 1
- SSZYXOKKPYHGLM-UHFFFAOYSA-N 1,3-dihydroxypropan-2-ylurea Chemical compound NC(=O)NC(CO)CO SSZYXOKKPYHGLM-UHFFFAOYSA-N 0.000 description 1
- WGFQARDLDGTVKH-UHFFFAOYSA-N 1-(1,3-dihydroxypropan-2-yl)-3-(2-hydroxyethyl)urea Chemical compound OCCNC(=O)NC(CO)CO WGFQARDLDGTVKH-UHFFFAOYSA-N 0.000 description 1
- SMEJDOFWKJVFCT-UHFFFAOYSA-N 1-(1-hydroxy-2-methylpropan-2-yl)-3-methylurea Chemical compound CNC(=O)NC(C)(C)CO SMEJDOFWKJVFCT-UHFFFAOYSA-N 0.000 description 1
- MEEMWRUUCUSUTN-UHFFFAOYSA-N 1-ethyl-3-(2-hydroxyethyl)urea Chemical compound CCNC(=O)NCCO MEEMWRUUCUSUTN-UHFFFAOYSA-N 0.000 description 1
- SYCFORXNZREGSA-UHFFFAOYSA-N 1-methyl-1-(1,3,4,5,6-pentahydroxyhexan-2-yl)urea Chemical compound NC(=O)N(C)C(CO)C(O)C(O)C(O)CO SYCFORXNZREGSA-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QJJLMANJJKBSNN-UHFFFAOYSA-N 2,3,4,5,6-pentahydroxyhexylurea Chemical compound NC(=O)NCC(O)C(O)C(O)C(O)CO QJJLMANJJKBSNN-UHFFFAOYSA-N 0.000 description 1
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 1
- IWJFGRNIFIABLP-UHFFFAOYSA-N 2,3-dihydroxypropylurea Chemical compound NC(=O)NCC(O)CO IWJFGRNIFIABLP-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- VHEYHMGSWDZXEN-UHFFFAOYSA-N 2-hydroxypropylurea Chemical compound CC(O)CNC(N)=O VHEYHMGSWDZXEN-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- AWNNECGZCPBURJ-UHFFFAOYSA-N 3-(2-hydroxyethyl)-1,1-bis(2-hydroxypropyl)urea Chemical compound CC(O)CN(CC(C)O)C(=O)NCCO AWNNECGZCPBURJ-UHFFFAOYSA-N 0.000 description 1
- DNPHEDNKXRMPAX-UHFFFAOYSA-N 3-hydroxypropylurea Chemical compound NC(=O)NCCCO DNPHEDNKXRMPAX-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- KHOITXIGCFIULA-UHFFFAOYSA-N Alophen Chemical compound C1=CC(OC(=O)C)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OC(C)=O)C=C1 KHOITXIGCFIULA-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241001530056 Athelia rolfsii Species 0.000 description 1
- 241000223678 Aureobasidium pullulans Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000001884 Cassia gum Substances 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241000596148 Crocus Species 0.000 description 1
- 235000004237 Crocus Nutrition 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- AEMOLEFTQBMNLQ-DTEWXJGMSA-N D-Galacturonic acid Natural products O[C@@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-DTEWXJGMSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 125000003436 D-mannopyranosyl group Chemical group [H]OC([H])([H])[C@@]1([H])OC([H])(*)[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H] 0.000 description 1
- 125000000214 D-xylosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)CO1)* 0.000 description 1
- 235000012040 Dahlia pinnata Nutrition 0.000 description 1
- 244000033273 Dahlia variabilis Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 241001134786 Furcellaria Species 0.000 description 1
- 241001134784 Furcellariaceae Species 0.000 description 1
- 241000755093 Gaidropsarus vulgaris Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- FZHXIRIBWMQPQF-UHFFFAOYSA-N Glc-NH2 Natural products O=CC(N)C(O)C(O)C(O)CO FZHXIRIBWMQPQF-UHFFFAOYSA-N 0.000 description 1
- 229920001706 Glucuronoxylan Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 101710108470 Hyalin Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241001428260 Hypneaceae Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 101710176222 Kallikrein-7 Proteins 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- HMFHBZSHGGEWLO-HWQSCIPKSA-N L-arabinofuranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@H]1O HMFHBZSHGGEWLO-HWQSCIPKSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102100038609 Lactoperoxidase Human genes 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001293495 Lactuca virosa Species 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000219730 Lathyrus aphaca Species 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000721701 Lynx Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102000055008 Matrilin Proteins Human genes 0.000 description 1
- 108010072582 Matrilin Proteins Proteins 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 108010093825 Mucoproteins Proteins 0.000 description 1
- 102000001621 Mucoproteins Human genes 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- QGGOCWIJGWDKHC-UHFFFAOYSA-N O4-Methyl-D-glucuronsaeure Natural products OC(=O)C(O)C(OC)C(O)C(O)C=O QGGOCWIJGWDKHC-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000178960 Paenibacillus macerans Species 0.000 description 1
- 241000282372 Panthera onca Species 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 229920002387 Phytoglycogen Polymers 0.000 description 1
- 108020005120 Plant DNA Proteins 0.000 description 1
- 241001428125 Polyideaceae Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 101800000789 Protease-polymerase p70 Proteins 0.000 description 1
- 101800000786 Protease-polymerase p76 Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 241000589180 Rhizobium Species 0.000 description 1
- 235000001537 Ribes X gardonianum Nutrition 0.000 description 1
- 235000001535 Ribes X utile Nutrition 0.000 description 1
- 235000016919 Ribes petraeum Nutrition 0.000 description 1
- 244000281247 Ribes rubrum Species 0.000 description 1
- 235000002355 Ribes spicatum Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UHFFFAOYSA-N Rohrzucker Natural products OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- 241000978782 Vachellia seyal Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WJFVEEAIYIOATH-KEWYIRBNSA-N [(2r,3r,4r,5r)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methyl hydrogen sulfate Chemical compound CC(=O)N[C@H]1C(O)O[C@H](COS(O)(=O)=O)[C@H](O)[C@@H]1O WJFVEEAIYIOATH-KEWYIRBNSA-N 0.000 description 1
- IVSHBCMTAKLBIE-UHFFFAOYSA-N [1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]urea Chemical compound NC(=O)NC(CO)(CO)CO IVSHBCMTAKLBIE-UHFFFAOYSA-N 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 1
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 229940051879 analgesics and antipyretics salicylic acid and derivative Drugs 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- 125000000089 arabinosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)CO1)* 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- UHHXUPJJDHEMGX-UHFFFAOYSA-K azanium;manganese(3+);phosphonato phosphate Chemical compound [NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O UHHXUPJJDHEMGX-UHFFFAOYSA-K 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- 125000001488 beta-D-galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- SRBFZHDQGSBBOR-KKQCNMDGSA-N beta-D-xylose Chemical group O[C@@H]1CO[C@@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-KKQCNMDGSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000019318 cassia gum Nutrition 0.000 description 1
- 229940105657 catalase Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 150000001773 cellobioses Chemical class 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940099898 chlorophyllin Drugs 0.000 description 1
- 235000019805 chlorophyllin Nutrition 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 229940107200 chondroitin sulfates Drugs 0.000 description 1
- 239000003042 chondroprotective agent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- QFSKIUZTIHBWFR-UHFFFAOYSA-N chromium;hydrate Chemical compound O.[Cr] QFSKIUZTIHBWFR-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 150000001944 cysteine derivatives Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 229940119744 dextran 40 Drugs 0.000 description 1
- 229940119743 dextran 70 Drugs 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- ORXJMBXYSGGCHG-UHFFFAOYSA-N dimethyl 2-methoxypropanedioate Chemical compound COC(=O)C(OC)C(=O)OC ORXJMBXYSGGCHG-UHFFFAOYSA-N 0.000 description 1
- 150000002013 dioxins Chemical class 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000001162 elastic cartilage Anatomy 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 150000002232 fructoses Chemical class 0.000 description 1
- 150000002243 furanoses Chemical class 0.000 description 1
- 125000002519 galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- BYSGBSNPRWKUQH-UJDJLXLFSA-N glycogen Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)O1 BYSGBSNPRWKUQH-UJDJLXLFSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 239000007970 homogeneous dispersion Substances 0.000 description 1
- 210000004276 hyalin Anatomy 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 150000002664 lycopenes Chemical class 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910001987 mercury nitrate Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- UNSKAUSCLTVFGO-KCDKBNATSA-N methyl (2s,3r,4s,5r)-2,3,4,5-tetrahydroxy-6-oxohexanoate Chemical compound COC(=O)[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O UNSKAUSCLTVFGO-KCDKBNATSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- MBLBDJOUHNCFQT-UHFFFAOYSA-N n-(3,4,5,6-tetrahydroxy-1-oxohexan-2-yl)acetamide Chemical compound CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 1
- WZZVUHWLNMNWLW-UHFFFAOYSA-N n-[5-[3-acetamido-5-[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound OC1C(NC(=O)C)C(O)OC(CO)C1OC1C(NC(C)=O)C(O)C(OC2C(C(O)C(O)C(CO)O2)NC(C)=O)C(CO)O1 WZZVUHWLNMNWLW-UHFFFAOYSA-N 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- DRXYRSRECMWYAV-UHFFFAOYSA-N nitrooxymercury Chemical compound [Hg+].[O-][N+]([O-])=O DRXYRSRECMWYAV-UHFFFAOYSA-N 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 150000004717 pyruvic acids Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 239000008132 rose water Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000012756 tartrazine Nutrition 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical class [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 1
- 229960000943 tartrazine Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 150000004043 trisaccharides Chemical group 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 150000003667 tyrosine derivatives Chemical class 0.000 description 1
- 238000002061 vacuum sublimation Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000003245 working effect Effects 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/14—Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Definitions
- the present invention relates to the field of cosmetic substrates, in particular those for single use, such as a makeup-removing disc or a wipe, for caring for, making up, cleansing and/or removing makeup from keratin materials, notably the skin, the face and the body, the nails and keratin fibres such as the hair or the beard.
- cosmetic substrates in particular those for single use, such as a makeup-removing disc or a wipe, for caring for, making up, cleansing and/or removing makeup from keratin materials, notably the skin, the face and the body, the nails and keratin fibres such as the hair or the beard.
- the invention is more particularly directed towards proposing a cosmetic substrate that is as natural as possible, and environmentally friendly, which is capable of efficiently replacing the existing cosmetic substrates, such as makeup-removing cotton wads.
- cotton discs are fibrous substrates derived from the physical transformation of cotton requiring more than 5000 litres of water per kg of cotton.
- the cultivation of cotton uses fertilizers and pesticides, and the cotton obtained is generally subjected to a chemical treatment based on chlorine (emission of dioxins) and heavy metals.
- Cosmetic wipes for their part, consist of a substrate made of a material of natural or synthetic origin, which is preferably a nonwoven, said substrate being impregnated with a composition suited to the desired purpose, for example cleansing or removing makeup from the skin or the eyes, or alternatively skincare or haircare.
- a composition suited to the desired purpose for example cleansing or removing makeup from the skin or the eyes, or alternatively skincare or haircare.
- Such wipes are commonly used since they are appreciated for their practical aspect, they are impregnated with the required and sufficient amount of treating or cleansing product, and are disposable. The use of these wipes avoids the handling and transportation of bottles containing the cosmetic compositions.
- wipes are criticized for their inappropriate use when they are disposed of in toilets instead of being placed in the dustbin, the problem being that, like all fibrous waste, they do not degrade, and block the evacuation pipes, overrun the wastewater networks and disrupt purification plants. Consumers are moreover in search of more natural products and the composition of conventional wipes may be a curb on their use. Finally, consumers are in search of alternatives having a different sensory feel when applied to the skin.
- the aim of the present invention is thus to find an alternative to the wipes and cotton wads used in cosmetics.
- novel cosmetic substrates such as konjac sponges or makeup blenders, at the present time, there is still not a cosmetic substrate or support which, simultaneously:
- hydro-degradable which means that after several hours of immersion in water, such as 4 hours 30 minutes, it does not remain cohesive but rather disintegrates and disperses in the water as biodegradable compounds.
- An object of the present invention is thus also to develop a novel cosmetic substrate of natural origin, preferably of plant origin, for single use, which is hydro-degradable and multifunctional, notably capable of fulfilling, within a single material, roles as a cotton wad, a wipe, a konjac sponge or even a makeup blender, while at the same time being more natural, more hygienic and more environmentally friendly both in its manufacture and in its destruction.
- Natural plant structures have excellent properties such as mechanical strength or rigidity combined with secondary properties which allow adaptation, modularity and multifunctionality.
- secondary properties such as mechanical strength or rigidity combined with secondary properties which allow adaptation, modularity and multifunctionality.
- their use directly as substrates in the cosmetic industry would give rise to problems of reproducibility.
- the present invention successfully meets the challenge of providing a substrate of natural origin, which is a biomimetic of the structuring of plant walls, while at the same time being industrially feasible starting with available and controlled raw materials, the substrate being multifunctional, and having the following features:
- cosmetic active agents notably cosmetic active agents that are usually unstable in liquid or aqueous formulation
- One subject of the present invention is thus a dry cosmetic substrate based on polysaccharides, intended for cleansing, removing makeup from, caring for and/or making up keratin materials, characterized in that it has an alveolar microscopic structure formed by non-crosslinked association of at least two polysaccharides with respective weight-average molecular masses of greater than 1000 g/mol:
- a second polysaccharide P2 being chosen: either from homopolysaccharides, or from heteropolysaccharides different from the first heteropolysaccharide and having a weight-average molecular mass of less than 1 000 000 g/mol.
- a subject of the present invention is also a process for manufacturing a substrate according to the invention, comprising the following steps:
- a hydrogel of at least two polysaccharides P1 and P2 for example at least partially dissolving in an aqueous phase, such as water, said at least two polysaccharides P1 and P2, by mixing at room temperature, to form a hydrogel, - freezing the hydrogel at a temperature below 0°C, preferably between -100°C and 0°C, preferably between -80 and 0°C, preferably at a temperature within the range from -80°C to -0.01 °C, preferably from -60°C to -4°C,
- a subject of the present invention is also a cosmetic process for caring for, cleansing, removing makeup from and/or making up keratin materials, which consists in applying thereto, notably to the skin or the hair, preferably to the skin, a substrate according to the invention.
- Said process may also comprise at least one step consisting in at least partially impregnating said substrate and/or in taking up with the aid of said substrate: water and/or a cosmetic composition and/or a fragrance.
- Figure 1 is an SEM photo of the structure of a plant wall of Elodeae (aquatic plants).
- Figure 2 is an SEM photo of a substrate according to the invention consisting of a combination of glucomannan + starch + glycerol, showing the interconnected porous network or the multicellular or alveolar multilayer structure which characterizes its microscopic structure, mimicking that of plant walls, notably of figure 1.
- Figure 3 schematically represents the application action protocol for evaluating the substrate.
- Figure 4 schematically represents the cleansing action protocol taken into consideration for testing the efficacy of the substrate according to the invention.
- the expression “at least one” is equivalent to “one or more” and, unless otherwise indicated (such as “more than...”, “less than...” or “between X and Y”), the limits of a range of values are included in that range (for example “in the range from X to Y”).
- the term “keratin materials” means the skin of the body, face and/or area around the eyes, the lips, the nails, mucous membranes, the eyelashes, the eyebrows, bodily hair, the scalp and/or head hair, or any other area of bodily skin. More particularly, the keratin materials according to the invention are the scalp, the hair and/or the skin. Preferably, the keratin material according to the invention is the skin.
- skin refers to all of the skin of the body, and preferably the skin of the face, neckline, neck, arms and forearms, or even more preferably the skin of the face, notably of the forehead, nose, cheeks, chin and area around the eyes.
- the substrates according to the present invention are cosmetic substrates, intended for topical use.
- cosmetic refers to a product that is compatible with the skin, mucous membranes and the integuments.
- the substrate according to the invention is advantageously non-crosslinked.
- non-crosslinked association of polysaccharides means an association of polysaccharides solely by weak bonds, such as hydrogen bonds, ionic bonds or van der Waals bonds, and not by a strong bond such as a covalent chemical bond.
- This structure is advantageously derived from cold (without heating) vacuum dehydration of a non-crosslinked hydrogel formed by simple dispersion in cold water (without heating) of at least two specific polysaccharides P1 , P2 as defined by the present invention.
- each of said polysaccharides P1 and P2 is at least partially water-soluble, at room temperature, notably within a temperature range included in the range from 20 to 25°C, preferably at 25°C.
- dry substrate means a solid material, which is preferably cohesive, and of anhydrous composition, having a water content by weight of less than 5%, preferably less than 4%, preferably less than 3%, preferably less than 2%, preferably less than 1.5% by weight of water relative to the total weight of substrate.
- the term “anhydrous” or “dry” is intended to qualify a substrate composition containing less than 3% water, preferably less than 2% water, preferably less than 1.5% by weight of water, in particular less than 1 % by weight of water, notably less than 0.7% water relative to its total weight, and, preferably, the substrate is free of water, notably in the case of a substrate that has been freeze-dried and then stored in dry form, for example in a hermetic package.
- the term “natural compound” means a compound which is obtained directly from the earth or soil, notably from plants via, where appropriate, one or more physical processes, for instance grinding, refining, distillation, purification or filtration.
- compound of natural origin means a natural compound that has undergone one or more additional chemical or industrial treatments, giving rise to modifications that do not affect the essential qualities of this compound and/or a compound predominantly comprising natural constituents that may or may not have undergone transformations as indicated above.
- the substrate according to the invention has an alveolar microscopic structure formed by association of at least two polysaccharides with respective weightaverage molecular masses of greater than 1000 g/mol:
- the first polysaccharide P1 being chosen from heteropolysaccharides
- the second polysaccharide P2 being chosen: either from homopolysaccharides, or from heteropolysaccharides different from the first heteropolysaccharide and having a weight-average molecular mass of less than 1 000 000 g/mol, each of said polysaccharides P1 and P2 preferably being at least partially water-soluble at room temperature, notably at 25°C.
- polysaccharide means any polymer consisting of several saccharides (or monosaccharides) having the general formula:
- At least one of said polysaccharides P1 , P2, preferably each of the two P1 and P2, comprises at least one pentose or one hexose, preferably a hexose, preferably glucose.
- heteropolysaccharides different from the first heteropolysaccharide means essentially the case in which P1 and P2 are heteropolysaccharides of different chemistry, and thus with a different saccharide composition, which is the preferred embodiment in the case of two heteropolysaccharides P1 , P2.
- this definition may also include (but this embodiment is not preferred) the case in which the two heteropolysaccharides have the same chemistry but a different weight-average molecular mass, in particular greater than 1000 g/mol and less than 1 000 000 g/mol for P2 and outside of this range for P1 , in other words greater than 1 000 000 g/mol for P1 in this case.
- At least partially water-soluble polysaccharide means any water-soluble or water-dispersible polysaccharide that is capable of giving a gelled solution after implementation at room temperature, notably at a temperature within the range from 20 to 25°C, preferably at 25°C.
- polysaccharides may be divided into several categories.
- Polysaccharides are generally distinguished depending on whether or not they are starchy.
- starchy polysaccharides examples include starches.
- non-starchy polysaccharides examples include polysaccharides produced by microorganisms; polysaccharides isolated from algae, and higher plant polysaccharides, such as homogeneous polysaccharides, in particular celluloses and derivatives thereof or fructosans, heterogeneous polysaccharides such as acacia gums, galactomannans, glucomannans and pectins, and derivatives thereof.
- the polysaccharides that are suitable for use in the invention may be homopolysaccharides such as fructans, glucans, galactans and mannans or heteropolysaccharides such as hemicellulose. Similarly, they may be linear polysaccharides such as pullulan or branched polysaccharides such as acacia gum and amylopectin, or mixed polysaccharides such as starch.
- polysaccharides of homopolysaccharide or heteropolysaccharide type that are suitable for use in the invention may be chosen from the starchy or non- starchy polysaccharides, listed below, and selected from this list according to their heteropolysaccharide or homopolysaccharide nature, as defined for each type of polysaccharide used according to the invention.
- Said at least two polysaccharides P1 , P2, which constitute the substrate according to the invention may notably be chosen from polysaccharides derived from microorganisms, polysaccharides isolated from algae and polysaccharides from higher plants.
- the polysaccharides are advantageously chosen from fructans, gellans, glucans, starches, which are preferably unmodified (such as those derived, for example, from cereals, for instance wheat, corn or rice, from vegetables, for instance yellow pea, and tubers, for instance potato or cassava), amylose, amylopectin, glycogen, dextrans, celluloses, mannans, xylans, lignins, arabans, galactans, galacturonans, chitin, chitosans, glucuronoxylans, arabinoxylans, xyloglucans, glucomannans, pectic acids and pectins, arabinogalactans, carrageenans, agars, glycosaminoglucans, acacia gums, gum tragacanths, ghatti gums, karaya gums, locust bean gums, galactomannans such as guar gums and non
- the derivatives obtained may be anionic, cationic, amphoteric or nonionic.
- the compounds of this type that may be used in the present invention are chosen from those described notably in Kirk-Othmer’s Encyclopedia of Chemical Technology, Third Edition, 1982, volume 3, pages 896-900, and volume 15, pages 439- 458, in Polymers in Nature by E.A. MacGregor and C.T. Greenwood, published by John Wiley & Sons, Chapter s, pages 240-328, 1980, in the book by Robert L.
- Xanthan is a heteropolysaccharide produced on an industrial scale by the aerobic fermentation of the bacterium Xanthomonas campestris. Its structure consists of a main chain of ⁇ (1 ,4)-linked 0-D-glucoses, similar to cellulose. One glucose molecule in two bears a trisaccharide side chain composed of an a-D-mannose, a 0-D-glucuronic acid and a terminal 0-D-mannose. The internal mannose residue is generally acetylated on carbon 6. About 30% of the terminal mannose residues bear a pyruvate group linked in chelated form between carbons 4 and 6.
- the charged pyruvic acids and glucuronic acids are ionizable, and are thus responsible for the anionic nature of xanthan (negative charge down to pH 1).
- the content of the pyruvate and acetate residues varies according to the bacterial strain, the fermentation process, the conditions after fermentation and the purification steps. These groups may be neutralized in commercial products with Na + , K + or Ca 2+ ions (Satia company, 1986).
- the neutralized form may be converted into the acid form by ion exchange or by dialysis of an acidic solution.
- Xanthan gums have a molecular weight of between 1 000 000 and 50 000 000 and a viscosity of between 0.6 and 1.65 Pa.s for an aqueous composition containing 1 % of xanthan gum (measured at 25°C on a Brookfield viscometer of LVT type at 60 rpm).
- Xanthan gums are represented, for example, by the products sold under the names Rhodicare by the company Rhodia Chimie, under the name SatiaxaneTM by the company Cargill Texturizing Solutions (for the food, cosmetic and pharmaceutical industries), under the name NovaxanTM by the company ADM, and under the names Kelzan® and Keltrol® by the company CP-Kelco.
- Pullulan is a polysaccharide consisting of maltotriose units, known under the name ⁇ (1 ,4)- ⁇ (1 ,6)-glucan. Three glucose units in maltotriose are connected via an ⁇ (1 ,4) glycoside bond, whereas the consecutive maltotriose units are connected to each other via an ⁇ (1,6) glycoside bond. Pullulan is produced by fermentation from starch, with the fungus Aureobasidium pullulans.
- Pullulan is produced, for example, under the reference Pullulan PF 20 by the group Hayashibara in Japan.
- Dextran is a neutral polysaccharide not bearing any charged groups, which is biologically inert, prepared by fermentation of beet sugar containing solely hydroxyl groups. It is synthesized from sucrose by fermentation in the presence of certain lactic acid bacteria, the most common being Leuconostoc mesenteroides and Streptococcus mutans. This branched polysaccharide consists of a sequence of glucose molecules forming a chain of variable lengths. The main chain consists of glucose molecules linked together via ⁇ (1 ,6) glycoside bonds and the branches are linked to the main chain via ⁇ (1,3) glycoside bonds (and in some cases by ⁇ (1 ,2) and ⁇ (1,4) bonds). Chemical structure of dextran: It is possible to obtain dextran fractions of different molecular weights from native dextran by hydrolysis and purification. Dextran may in particular be in the form of dextran sulfate.
- Dextran is represented, for example, by the products sold under the name Dextran or Dextran T by the company Pharmacosmos, or under the name Dextran 40 Powder or Dextran 70 Powder by the company Meito Sangyo Co.
- Dextran sulfate is sold by the company PK Chemical A/S under the name Dextran sulfate.
- Succinoglycan is an extracellular polymer of high molecular weight produced by bacterial fermentation, consisting of octasaccharide repeating units (repetition of 8 sugars). These units are synthesized in the membranes of the microorganism linked to the isoprenoid lipids.
- the main chain contains 3 glucoses and 1 galactose, and the side chain contains 4 glucoses.
- the sugars are linked together via [3(1 ,4) and ⁇ (1 ,3) glycoside bonds.
- the pyruvate substituent is attached to the last glucose of the side chain, whereas succinate may be linked to one of the other two glucoses of the same side chain.
- the base unit of said succinoglycans may contain residues of other organic acids, such as pyruvyl or acetyl residues, and also of other sugars such as glucuronic acid and/or mannose.
- the mole ratios between glucose and such organic acid residues are generally between (5 to 8)/(0.01 to 2).
- the mole ratios between said other sugars and glucose are generally between (0 to 1 )/(5 to 8).
- Succinoglycans may be obtained by microbial fermentation, for example by fermentation of a medium including at least one carbon source, by means of a microorganism which preferably belongs to the Arthrobacter genus, such as Arthrobacter stabilis, to the Agrobacterium genus, such asAgrobacterium tumefaciens, Agrobacterium radiobacter or Agrobacterium rhizogenes, to the Rhizobium genus or to the Alcaligenes genus, such asAlcaligenes faecalis.
- Arthrobacter stabilis to the Agrobacterium genus, such asAgrobacterium tumefaciens, Agrobacterium radiobacter or Agrobacterium rhizogenes, to the Rhizobium genus or to the Alcaligenes genus, such asAlcaligenes faecalis.
- the fermentation media including the carbon source and the fermentation processes are widely described in the literature.
- Succinoglycan is an anionic polysaccharide which has the particular feature of undergoing a helix-coil transition, induced by a temperature change. This conformational transition is highly cooperative, bringing about a substantial change in the rigidity of the polymer.
- Succinoglycans are sold, for example, under the name Rheozan by the company Rhodia. Scleroglucan
- Scleroglucan is a nonionic branched homopolysaccharide consisting of p-D-glucan units.
- the molecules consist of a linear main chain formed from D-glucose units linked via ⁇ (1 ,3) bonds and of which one in three is linked to a side D-glucose unit via a ⁇ (1 ,6) bond.
- polysaccharides are obtained by fermentation of a medium based on sugar and mineral salts, under the action of a microorganism of Sclerotium type, such as Sclerotium glucanium and Sclerotium rolfsii.
- Sclerotium type such as Sclerotium glucanium and Sclerotium rolfsii.
- Scleroglucan is sold, for example, under the name Amigel by the company Alban Muller, or under the name ActigumTM CS by the company Cargill.
- the polysaccharide of the composition according to the invention may be a galactan chosen notably from agar and carrageenans.
- Carrageenans are anionic polysaccharides constituting the cell walls of various red algae (Rhodophyceae) belonging to the Gigartinacae, Hypneaceae, Furcellariaceae and Polyideaceae families. They are generally obtained by hot aqueous extraction from natural strains of said algae. These linear polymers, formed by disaccharide units, are composed of two D-galactopyranose units linked alternately by ⁇ (1 ,3) and ⁇ (1 ,4) bonds. They are highly sulfated polysaccharides (20-50%) and the a-D-galactopyranosyl residues may be in 3,6-anhydro form.
- carrageenans which bear one sulfateester group
- iota-carrageenans which bear two sulfate-ester groups
- lambda- carrageenans which bear three sulfate-ester groups.
- Carrageenans notably have the following chemical structures:
- Carrageenans are composed essentially of potassium, sodium, magnesium, triethanolamine and/or calcium salts and of sulfate esters of polysaccharides.
- the physicochemical properties and the uses of these polysaccharides as gelling agents are based on their capacity to establish coil-helix conformational transitions as a function of the thermal and ionic environment [Kloareg et al. Oceanography and Marine Biology - An annual review 26: 259-315 (1988)].
- Carrageenans are sold notably by the company SEPPIC under the name Solagum®, by the company Gelymar under the names Carragel®, Carralact® and Carrasol®, by the company Cargill under the names SatiagelTM and SatiagumTM, and by the company CP-Kelco under the names Genulacta®, Genugel® and Genuvisco®.
- Galactans of agar type are galactose polysaccharides contained in the cell wall of some of these species of red algae (Rhodophyceae).
- Agar-agar is a mixture of polysaccharides (agarose and agaro ⁇ eZtin) of high molecular mass, between 40 000 and 300 000 g.mol -1 . It is obtained by manufacturing algal extraction liquors, generally by autoclaving, and by treating these liquors which comprise about 2% of agar-agar, so as to extract the latter.
- Agar is produced, for example, by the group B&V Agar Producers under the names Gold Agar, Agarite and Grand Agar by the company Hispanagar, and under the names Agar-Agar, QSA (Quick Soluble Agar), and Puragar by the company Setexam.
- Furcellaran is obtained commercially from Furcellaria fasztigiata red algae, which are mainly present in the seas of northern Europe. Its structure is very close to that of carrageenans.
- Furcellaran is produced, for example, by the company Est-Agar.
- the polysaccharide P1 , P2 present in the composition according to the invention may be a glucosan, notably chosen from native or modified starches, dextrins and derivatives, celluloses and derivatives or fructosans.
- the starches that may be used in the present invention are more particularly macromolecules in the form of polymers consisting of elementary moieties which are anhydroglucose units (dextrose), linked via ⁇ (1 ,4) bonds, of chemical formula (C 6 H 10 O 5 )n.
- the number of these moieties and their assembly make it possible to distinguish amylose, a molecule formed from about 600 to 1000 linearly linked glucose molecules, and amylopectin, a polymer branched approximately every 25 glucose residues ( ⁇ (1,6) bond).
- the total chain may include between 10 000 and 100 000 glucose residues.
- Starch is described in particular in Kirk-Othmer’s Encyclopedia of Chemical Technology, 3rd edition, volume 21 , pages 492-507, Wiley Interscience, 1983. Chemical structure of starch:
- amylose and of amylopectin vary as a function of the botanical origin of the starches. On average, a sample of native starch consists of about 25% amylose and 75% amylopectin.
- Starch may be in the form of semicrystalline granules: amylopectin is organized in leaflets, amylose forms a less well organized amorphous zone between the various leaflets.
- Amylose is organized in a straight helix with six glucoses per turn. It dissociates into assimilable glucose under the action of enzymes, amylases, all the more easily when it is in amylopectin form. Specifically, the helical formation does not promote the accessibility of starch to the enzymes.
- Starches are generally in the form of a white powder, which is insoluble in cold water, of which the elemental particle size ranges from 3 to 100 microns.
- starch paste By treating it with hot water, starch paste is obtained. It is exploited in industry for its thickening and gelling properties.
- the botanical origin of the starch molecules used in the present invention may be cereals or tubers.
- the starches are chosen, for example, from corn starch, rice starch, cassava starch, barley starch, potato starch, wheat starch, sorghum starch and pea starch.
- the native starches are represented, for example, by the products sold under the names C*AmilogelTM, Cargill GelTM, C* GelTM, Cargill GumTM, DryGelTM and C*Pharm GelTM by the company Cargill, under the name Amidon de Mais by the company Roquette, and under the name Tapioca Pure by the company National Starch.
- Cyclodextrins are a family of cyclic oligosaccharides composed of ⁇ (1 ,4)-linked glucopyranose subunits. These natural products resulting from the degradation of starch by the bacterium Bacillus macerans were discovered in 1891 by V Amsterdam. Three families are mainly used or studied: a-, ⁇ -and y-cyclodextrins, depending on whether they are formed from 6, 7 or 8 subunits (-families of several tens of subunits have been synthesized for research purposes).
- Cyclodextrins are notably oligosaccharides of formula:
- x may be a number equal to 4 (which corresponds to a-cyclodextrin), to 5 (P-cyclodextrin) or to 6 (y-cyclodextrin).
- cyclodextrins may be obtained from natural cyclodextrins: the hydroxyl groups of the glucopyranose units may be aminated, esterified or etherified. The synthesis of these derivatives is often for the purpose of improving the solubility.
- cyclodextrins that have been the most extensively studied are p-cyclodextrin (BCD, natural), hydroxypropyl-p-cyclodextrin (HPCD) and methyl-p-cyclodextrin (MCD).
- Use may notably be made of a p-cyclodextrin sold by the company Wacker under the name Cavamax W7 and a y-cyclodextrin sold by the company Wacker under the name Cavamax W8.
- the cyclodextrin derivatives are, for example, methyl cyclodextrins such as the methyl- P-cyclodextrin sold by the company Wacker under the name Cavasol W7.
- the polysaccharide P1 , P2 according to the invention may also be a cellulose or a derivative thereof, notably cellulose ethers or esters (e.g.: methylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxymethylpropylcellulose, cellulose acetate, cellulose nitrate, nitrocellulose).
- cellulose ethers or esters e.g.: methylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxymethylpropylcellulose, cellulose acetate, cellulose nitrate, nitrocellulose.
- the invention may also contain a cellulose-based associative polymer.
- cellulose-based compound means any polysaccharide compound bearing in its structure linear sequences of anhydroglucopyranose residues (AGUs) linked together via ⁇ (1 ,4) glycoside bonds.
- the repeating unit is the cellobiose dimer.
- the AGUs are in chair conformation and bear 3 hydroxyl functions: 2 secondary alcohols (in position 2 and 3) and a primary alcohol (in position 6).
- the polymers thus formed combine together via intermolecular bonds of hydrogen bond type, thus giving the cellulose a fibrillar structure (about 1500 molecules per fibre).
- the degree of polymerization differs enormously depending on the origin of the cellulose; its value may range from a few hundred to several tens of thousands.
- Cellulose has the following chemical structure:
- the polysaccharide P1 , P2 present in the composition according to the invention may notably be a fructosan chosen from inulin and derivatives thereof (notably dicarboxy and carboxymethyl inulins).
- Fructans or fructosans are oligosaccharides or polysaccharides comprising a sequence of anhydrofructose units optionally combined with one or more saccharide residues other than fructose.
- Fructans may be linear or branched.
- Fructans may be products obtained directly from a plant or microbial source or alternatively products of which the chain length has been modified (increased or decreased) by fractionation, synthesis or hydrolysis, in particular enzymatic.
- Fructans generally have a degree of polymerization from 2 to about 1000 and preferably from 2 to about 6O.Thr ee groups of fructans are distinguished. The first group corresponds to products of which the fructose units are for the most part linked via ⁇ (2,1) bonds. These are essentially linear fructans such as inulins. The second group also corresponds to linear fructoses, but the fructose units are essentially linked via ⁇ (2,6) bonds. These products are levans. The third group corresponds to mixed fructans, i.e. containing ⁇ (2,6) and ⁇ (2,1) sequences. These are essentially branched fructans, such as graminans. The preferred fructans in the compositions according to the invention are inulins.
- Inulin may be obtained, for example, from chicory, dahlia or Jerusalem artichoke.
- the inulin used in the composition according to the invention is obtained, for example, from chicory.
- Heterogeneous polysaccharides are:
- the polysaccharides that may be used according to the invention may be gums, for instance cassia gum, karaya gum, konjac gum, gum tragacanth, acacia gum or gum arabic.
- Acacia gum of which Senegal gum (Acacia seyal, Leguminosae family) is the main variety, consists of a solidified descending sap exudate, amalgamated naturally or by incision, on the trunk and at the foot of trees of the acacia family.
- Acacia gum is a highly branched acidic polysaccharide which is in the form of mixtures of potassium, magnesium and calcium salts.
- the monomer elements of the free acid (arabic acid) are D-galactose, L-arabinose, L-rhamnose and D-glucuronic acid. It is acknowledged that acacia gums are composed of at least two polysaccharide fractions of different structures. The fraction of higher molecular mass contains a modest proportion of amino acids but which is decisive for its properties. The indicated average molecular mass oscillates between 200 and 300 kDa.
- Acacia gum is found commercially in the form of powder or of non-ground crystals that are more or less round of yellow-white to yellow-brownish colour.
- the outer surface of the crystals is dull and split and their fractures are vitreous; they are often also traversed by fine fissures.
- the gum is insipid and odourless. It is soluble in water and insoluble in alcohol.
- Acacia gum is characterized by three main fractions: an arabinogalactan (AG) fraction with a very small protein fraction, representing 88% of the gum and having a molecular mass of 250 000 Da, an arabinogalactan-protein (AGP) complex having a high molecular mass (1.5*10 6 ) - the protein complex (AGP) representing about 10% by weight of the gum, and a glycoprotein (Gl) with a molecular mass of 200 000 Da, making up 1.2% of the gum.
- AG arabinogalactan
- AGP arabinogalactan-protein
- Gl glycoprotein
- the carbohydrate blocks are linked together by a main polypeptide chain.
- the carbohydrate blocks consist of a ⁇ (1,3)-linked galactopyranose backbone, with numerous branches (1 ,6)-linked to the galactopyranose residues and containing the sugars arabinofuranose, arabinopyranose (Ara), rhamnopyranose (Rha), glucuronic acid (GlcA) and 4-O-methylglucuronic acid.
- Acacia gum may be precipitated in the presence of trivalent cations and with salts such as mercury nitrate, borates and silicates.
- the acacia gum used for the present invention is represented, for example, by the products sold under the name EficaciaTM by the company ColloTdes Naturels International, by the product sold under the name Gum Arabic Quick Gum Type 8074 by the company Max Haenelt, by the product sold under the name Gomme Arabique Poudre 396D sold by the company Alland & Robert, and by the product sold under the name Ticamulsion B-2001 by the company TIC Gums.
- Gum tragacanth also known as tragacanth or dragon gum, is an exudate obtained from the dried mucilaginous sap of about 20 species of plants of the genus Astracantha (formerly known as Astragalus) originating from south-eastern Europe and from southwestern Asia.
- This gum is a complex mixture of several polysaccharides.
- the two main fractions are tragacanthin (60-70%) and bassorin, also known as tragacanthic acid (30-40%).
- tragacanthin dissolves to form a colloidal hydrosol, whereas the insoluble bassorin swells to form a gel.
- an adhesive paste is obtained.
- the constituent sugar residues of this arabinogalactan are 75% L-arabinose, 12% D-galactose, 3% D-galacturonic acid methyl ester and L-rhamnose.
- Tragacanthic acid is water-soluble and consists of a (1,4)-linked a-D-galactopyranosyluronic acid backbone, with short branches such as (3(1 ,3)-linked D-xylopyranose residues, (3(1 ,3)- linked D-xylopyropyranosyl-1 ,2- a-L-fucopyranose dimers and (3(1 ,3)-linked D-xylopyranose- 1 ,2-D-galactopyranose dimers.
- the constituent sugars of gum tragacanth are thus, in relative proportions: 43% D-galacturonic acid, 40% D-xylose, 10% L-fucose and 4% D-galactose.
- the average molecular mass of tragacanthic acid is about 840 000 Da.
- Karaya gum is a partially acetylated polysaccharide, of high molecular weight, exuded by trees of the species Sterculia (urens and setigera), and is one of the natural gums that is the least water-soluble. It swells to give a viscous colloidal dispersion.
- Karaya gum is a highly acetylated acidic polysaccharide, with a backbone consisting of an alternation of (1 ,4)-linked ⁇ -D-galacturonopyranosyluronic acid units and of (1,2)- linked a-L-rhamnopyranosyl residues.
- ⁇ -D-Galactopyranosyl and D- glucuronopyranosyluronic acid groups are branched on the oxygens (02 and 03) of the galacturonic acid residues, whereas half of the rhamnose residues are (1,4)-linked (at 04) to
- the molecule also contains 13% by weight of acetyl groups.
- Karaya gum is sparingly water-soluble, but it readily swells in cold water to occupy several times its original volume, particularly at a low particle size ( ⁇ 200 mesh), giving a dispersion which appears homogeneous.
- the karaya gum used for the present invention is represented, for example, by the products sold under the name Gomme Karaya Poudre by the company Alland & Robert.
- Galactomannans (guar, locust bean, fenugreek, tara gum) and derivatives (guar phosphate, hydroxypropyl guar, etc.):
- Galactomannans are nonionic polyosides extracted from the endosperm of leguminous seeds, of which they constitute the storage carbohydrate.
- Galactomannans are macromolecules consisting of a main chain of ⁇ (1 ,4)-linked D-mannopyranose units, bearing side branches consisting of a single D-galactopyranose unit ⁇ (1 ,6)-linked to the main chain.
- the various galactomannans differ, firstly, by the proportion of a-D-galactopyranose units present in the polymer, and secondly by significant differences in terms of distribution of galactose units along the mannose chain.
- the mannose/galactose (M/G) ratio is about 2 for guar gum, 3 for tara gum and 4 for locust bean gum.
- the guar molecule thus contains on average twice as many branches as locust bean gum. However, within one and the same sample, this ratio can vary according to the fractions.
- Knowledge of the M/G ratio constitutes one of the means for characterizing the sample, although it does not provide any information regarding the statistical distribution of the galactosyl residues on the main chain.
- Galactomannans have the following chemical structure: Tara gum is characterized by a side chain distribution that is more statistically random, whereas locust bean gum is characterized by a distribution that is not statistically random and irregular, with an alternation of unsubstituted blocks of intermediate length (smooth regions) and branched blocks (hairy regions). Guar meal has very few smooth regions, with a very regular distribution of the galactose side chains.
- the products that may be used according to the invention may be partially depolymerized galactomannans, consequently having reduced viscosities. These depolymerizations are obtained by acid hydrolysis, oxidation or enzymatic degradation. Guar
- Guar gum is characterized by a mannose:galactose ratio of the order of 2:1.
- the galactose group is regularly distributed along the mannose chain.
- guar gums that may be used according to the invention may be nonionic, cationic or anionic.
- the unmodified nonionic guar gums are, for example, the products sold under the names Vidogum GH, Vidogum G and Vidocrem by the company Unipektin and under the name Jaguar by the company Rhodia, under the name Meypro® Guar by the company Danisco, under the name ViscogumTM by the company Cargill, and under the name Supercol® guar gum by the company Aquaion.
- hydrolysed nonionic guar gums that may be used according to the invention are represented, for example, by the products sold under the name Meyprodor® by the company Danisco.
- modified nonionic guar gums that may be used according to the invention are preferably modified with C 1 -C 6 hydroxyalkyl groups.
- compositions in accordance with the invention may also comprise a cationic galactomannan gum.
- the galactomannan gum is a cationic guar gum.
- the cationic galactomannan gums preferably have a cationic charge density of less than or equal to 1.5 meq./g, more particularly between 0.1 and 1 meq./g.
- the charge density may be determined by the Kjeldahl method. It generally corresponds to a pH of the order of 3 to 9.
- Locust bean gum is extracted from the seeds of the locust bean tree (Ceratonia siliqua), which is an evergreen tree originating from AMD and Asia Minor, but which is grown throughout the Mediterranean coastline.
- locust bean tree Ceratonia siliqua
- the galactose sugars are not equally regularly distributed along the chain, but have a tendency to be grouped together in blocks.
- the chains have an irregular structure with alternating “smooth” zones and substituted zones.
- the locust bean gum that may be used in the present invention may be chemically modified, via the same chemical modifications as those described previously for guar gum.
- the unmodified locust bean gum that may be used in the present invention is sold, for example, under the name ViscogumTM by the company Cargill, under the name Vidogum L by the company Unipektin and under the name Grinsted® LBG by the company Danisco.
- the tara gum that may be used in the present invention may be chemically modified, via the same chemical modifications as those described previously for guar gum.
- the tara gum that may be used is sold, for example, under the name Vidogum SP by the company Unipektin.
- Glucomannans (konjac gum):
- Glucomannan is a polysaccharide of high molecular weight (500 000 ⁇ Mglucomannan ⁇ 2 000 000) composed of D-mannose and D-glucose units with a branch every 50 or 60 units approximately. It is found in wood, but is also the main constituent of konjac gum. Konjac (Amorphophallus konjac) is a plant of the Araceae family.
- Pectins or more broadly pectic substances, are polysaccharides, linked to carbohydrates. They are substances that are exclusively of plant origin. Pectin is present in large amount in certain algae, and in currant, apple, quince and lemon seeds and zests. Pectins are extracted from the raw material by solubilization in acidic medium under hot conditions, and by precipitation from alcohol. The precipitate is then washed with a sodium hydroxide solution in order to obtain the desired pH.
- Pectins are polymers of acid polysaccharides. Pectins are linear polymers of a-D- galacturonic acid (at least 65%) linked in positions 1 and 4 with a certain proportion of carboxylic groups esterified with a methanol group. About 20% of the sugars constituting the pectin molecule are neutral sugars (L-rhamnose, D-glucose, D-galactose, L-arabinose, D-xylose). L-Rhamnose residues are found in all pectins, incorporated into the main chain in positions 1 ,2. They are responsible for the nonlinear nature of the main chain (cf. chemical structure). Their molecular weight is about 10 5 g/mol.
- Uronic acid molecules bear carboxyl functions. This function gives pectins the capacity for exchanging ions, when they are in COO- form. Divalent ions (in particular calcium) have the capacity of forming ionic bridges between two carboxyl groups of two different pectin molecules.
- a certain proportion of the carboxylic groups are esterified with a methanol group.
- the natural degree of esterification of a pectin may range between 70% (apple, lemon) and 10% (strawberry) depending on the source used.
- pectins with a high degree of esterification it is possible to hydrolyse the -COOCH3 groups so as to obtain weakly esterified pectins.
- the chain is thus more or less acidic.
- HM (high-methoxy) pectins are thus defined as having a degree of esterification of greater than 50%
- LM (low-methoxy) pectins are defined as having a degree of esterification of less than 50%.
- the degree of esterification influences the gelling properties of HM pectins.
- the ester group is less hydrophilic than the acid group and, consequently, an HM pectin (with a high degree of esterification) gels at a higher temperature than an LM pectin (with a low degree of esterification). The difference is reflected in terms of rapid, medium and slow gelling.
- Pectins are notably sold by the company Cargill under the name UnipectineTM, by the company CP-Kelco under the name Genu, and by Danisco under the name Grinsted Pectin.
- polysaccharides that may be used according to the invention, mention may also be made of polysaccharides derived from biotechnology. This is the case, for example, for chitin, chitosan and derivatives (chitosan 0-glycerophosphate, carboxymethylchitin, etc.).
- Chitin is a polysaccharide amino sugar, formed from acetylglucosamine groups (N- acetyl-D-glucose-2-amine) linked together by a bond of the (1 ,4) type. It is this type of bond which links the glucose groups in the cellulose molecule.
- the chemical name of the molecule is poly-N-acetyl-D-glucosamine, ⁇ (1 ,4)-2- acetamido-2-deoxy-D-glucose.
- Chitin is one of the constituents of the cuticle of insects, spiders and crustaceans, and thus has a protective role. When combined with calcium carbonate, it becomes rigid and then forms the exoskeleton of crustaceans and of all shell-bearing animals such as snails.
- Chitosan is a polysaccharide composed of the random distribution of ⁇ (1 ,4)-linked D-glucosamine (deacetylated unit) and of N-acetyl-D-glucosamine (acetylated unit). It is produced by chemical deacetylation (in an alkaline medium) or enzymatic deacetylation of chitin, the component of the arthropod (crustacean) exoskeleton or of the cephalopod (squid, etc.) endoskeleton or else of the fungal wall. This raw material is demineralized by treatment with hydrochloric acid, then deproteinated in the presence of sodium hydroxide or potassium hydroxide and, finally, decolourized using an oxidizing agent.
- the degree of acetylation is the percentage of acetylated units relative to the number of total units; it can be determined by Fourier transform infrared (FTIR) spectrometry or by titration with a strong base.
- FTIR Fourier transform infrared
- the border between chitosan and chitin corresponds to a DA of 50%: below this the compound is called chitosan, above it, it is called chitin.
- Chitosan is soluble in an acidic medium, unlike chitin which is insoluble. It is important to distinguish between the degree of acetylation (DA) and the degree of deacetylation (DD).
- Chitin is a particularly efficient moisturizer. Its advantage is twofold: it provides water and prevents dehydration. Furthermore, the great advantage of chitin and derivatives thereof is the persistence of this moisturizing power over time.
- chitosan forms a protective and tensioning film at the surface of the skin, which is capable of fixing other active principles for the skin.
- other moisturizers, sunscreens or organic acids or other active principles may be associated with chitin derivatives. Chitin is considered to promote their effects.
- the products that may be used according to the invention are, for example, those sold by the company France-Chitine.
- Glycosaminoglycans GAG
- Mention may notably be made of hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate or heparin and heparan sulfate.
- glycosaminoglycans GAG
- AAG glycosaminoglycans
- glucosamine GlcN
- galactosamine GalN
- glucuronic acid GlcA
- IdoA iduronic acid
- galactose Gal
- the glucosamine is either N-sulfated (GIcNS) or N-acetylated (GIcNac).
- the galactosamine is always N-acetylated (GalNac).
- GAG chains may be covalently bonded to a protein to form proteoglycans.
- GAGs comprise chondroitin sulfate (elastic cartilage, hyalin cartilage, bone, dermis, cornea), dermatan sulfate (dermis, tendon, ligament, fibrous cartilage), keratan sulfate (cartilage, cornea), heparin/heparan sulfate (liver, lung, aorta) and hyaluronic acid.
- Hyaluronic acid is a polymer of disaccharides which are themselves composed of D-glucuronic acid and D-N-acetylglucosamine linked together via alternating ⁇ (1 ,4) and ⁇ (1,3) glycoside bonds.
- the polymers of this repeating unit may have a size of between 10 2 and 10 4 kDa in vivo.
- Hyaluronic acid is stable from an energetic viewpoint, partly on account of the stereochemical aspects of the disaccharides of which it is composed.
- Hyaluronic acid consists of about 50 000 disaccharide units, it is the size of a bacterium and has the appearance of a gel.
- Hyaluronic acid is mainly obtained industrially via two different processes: extraction of cockerel crests (after grinding, chemical treatment and purification) or bacterial fermentation (hyaluronic acid filaments are synthesized by genetically modified bacteria).
- Sodium hyaluronate is the sodium salt of hyaluronic acid.
- Chondroitin sulfate is a glycosaminoglycan present in connective tissue.
- Chondroitin sulfate is a component of cartilage matrix. Its function is to maintain the osmotic pressure by absorbing water and to aid in hydrating cartilage. It also contributes towards the flexibility and elasticity of bone. Even more importantly, it serves as a chondro-protective agent by protecting cartilage against enzymatic reactions and against damage mediated by free radicals (including the nitrogen monoxide released by chondrocytes).
- the base unit of chondroitin sulfate is glucuronic acid ⁇ (1 ,3) N-acetylgalactosamine 6-sulfate. Each unit is linked to the next one by a ⁇ (1 ,4) bond. Chondroitin sulfate varies in its composition as a function of the animal species even though the base structure is mainly unchanged.
- Heparin is a molecule which is a member of the glycosaminoglycans (GAG).
- the polysaccharide P1 , P2 is hyaluronic acid.
- Flour contains fragments of the primary walls of the starchy endosperm of wheat; they belong essentially to one family of polysaccharides: arabinoxylans. These are polymers of xylose and arabinose, all grouped under the name “pentosans”. The arabinoxylan from wheat seeds is composed of ⁇ -D-xylopyranose residues (Rodionova et al., 1992).
- Xylans are consisting of a main chain of ⁇ (1,4)-linked D-xylose units on which are found three substituents (Rouau & Thibault, 1987): acid units, a-L-arabinofuranose units, side chains which may contain arabinose, xylose, galactose and glucuronic acid.
- Arabinoxylan generally consists of 1500-5000 a-L-arabinofuranose and D- xylopyranose residues (Chaplin, 2004).
- the weight-average molecular mass may also be determined by size exclusion chromatography coupled online with multi-angle light scattering and refractometry: SEC/MALS/RI coupling.
- SLS size exclusion chromatography
- MALS multi-angle light scattering
- Multi-angle light scattering is based on measurement of the scattered intensity of a solute in solution which is proportional to its concentration and to its molar mass.
- the scattered intensity may also vary according to the angle of observation as a function of the size of the scattering object, in particular its radius of gyration (Rg).
- the analysis of the samples may be performed at 25°C by coupling size exclusion chromatography (SEC) with a multi-angle static light scattering (MALS) detector (Dawn Heleos, Wyatt Technology, USA) 18 angles (normalized with the detector at 90°), and a differential refractive index (DRI) detector (Optilab, Wyatt Technology, USA), indicating the concentration of polysaccharide (Ci) of each fraction eluted by the SEC.
- SEC size exclusion chromatography
- MALS multi-angle static light scattering
- DRI differential refractive index
- M w weight-average molecular mass of the polysaccharide
- NA Avogadro number
- dn/dc refractive index increment of the solution (ml/g)
- the use of SEC requires the samples to be fully soluble in the analysis eluent and not to be retained on the columns.
- the polysaccharides are generally dissolved in the chromatography eluents used for their analysis, namely 0.1 M pH 4.5 sodium nitrate.
- FFF field flow fractionation
- the polysaccharides that may be used in the invention must in fact have respective weight-average molecular masses of greater than 1000 g/mol, it being pointed out that:
- the first polysaccharide P1 is chosen from heteropolysaccharides
- the second polysaccharide P2 is chosen: either from homopolysaccharides, or from heteropolysaccharides different from the first heteropolysaccharide and having a weight-average molecular mass of less than 1 000 000 g/mol.
- said second polysaccharide P2 is a homopolysaccharide with a weightaverage molecular mass of greater than 1 000 000 g/mol. Even more pore preferably, the substrate according to the invention comprises:
- said two polysaccharides P1 , P2 are hydrocolloids, i.e. water-soluble polysaccharides which spontaneously form a hydrogel in aqueous solution, when they represent a total weight content of polysaccharides (P1+P2) within the range from 0.5% to 5%, preferably from 1% to 3%, preferably from 1% to 2% by weight relative to the total weight of the aqueous solution (P1+P2+water).
- the weight ratio P1 :P2 is between 1 :4 and 4:1 , preferably within the range from 1 :3 to 3:1 , preferably within the range from 1 :2 to 2:1 ; preferably, the weight ratio P1 :P2 is 1 :1.
- P1 and P2 are chosen from the following list of polysaccharides: glucomannan, galactomannan, gellan gum, xanthan, xilogel, starch, cellulose, amylose, curdlan, pullulan, carrageenan, laminarin, agar, alginate, chitosan, guar gum, konjac gum, locust bean gum, sclerotium gum, maltodextrins, modified polysaccharide which is water-soluble at 25°C, such as carboxymethyl starch, distarch phosphate, hydroxymethylcellulose, and mixtures thereof; preferably, P1 is glucomannan and P2 is starch.
- the substrate according to the invention uses at least one of the combinations (A1 to A22) of polysaccharides of the type P1 , P2 according to the invention, of Table 1 below, as listed in each of the lines 1 to 22.
- Table 1 indicates for each polysaccharide of each combination whether it is a homopolysaccharide or a heteropolysaccharide, its weight-average molecular mass and its saccharide composition.
- Mw The weight-average molecular mass, abbreviated hereinbelow as Mw, is indicated as follows: h/m/l, with h for high Mw: hMw > 1 MDa (in the tables hereinbelow, noted as h) m for medium Mw: 1 kDa ⁇ mMw ⁇ 1 MDa (in the tables hereinbelow, noted as m) I for low Mw: IMw ⁇ 1 kDa (in the tables hereinbelow, noted as I).
- the structure of the substrate of the invention is preferably obtained by freezing and vacuum dehydration starting with a composition comprising said polysaccharides P1, P2, in which P1 and/or P2 are at least partially, or even totally, introduced in the form of a natural fragment, preferably a plant fragment, said at least one natural fragment being chosen from plants, notably plant byproducts, byproducts derived from the agricultural sector or from the food sector, commonly eliminated ingredients of plant origin, preferably chosen from: peels, pulps, peelings, cores, tops, leaves, fibres, stalks, flowers, petals, fruit, berries, vegetables, fruit slices or skins, vegetable slices or skins, seeds, pips, beans, cereals, brans, starch-rich plants, and mixtures thereof; or alternatively from algae and microalgae, bacteria, yeasts and/or fungi, each fragment being, without preference, either in a raw form or in the form of a processed extract, preferably in raw, sparing
- composition of the substrate according to the invention thus comprises one or more fragments of one or more plants in dehydrated form, notably a part of a plant, fruit or vegetable.
- fragment means a piece or a part of a plant, obtained, for example, by tearing or milling the plant, or by cutting up said plant.
- fragments of one or more plants means that the composition of the substrate comprises either several fragments of one and the same species of plant, or that the composition of the substrate comprises several fragments of several different species of plants.
- a plant may be contained in its entirety in the composition of a substrate according to the invention.
- the fragments of one or more plants are chosen from flower petals, whole flowers, flower buds, leaves, algae, plant stems, roots, all or a part of fruit or vegetables such as fruit or vegetable skins, in their entirety or in pieces, and mixtures thereof; more preferentially from flower petals, leaves, fruit, vegetables, algae, in their entirety or in pieces, and mixtures thereof.
- Plant fragments are chosen, for example, from Aloe vera, fruit such as those of Cucurbitaceae such as marrow, fruit skins such as tomato skin, banana skin, mango skin, peach skin, cucumber, flower petals such as rose petals, envelopes such as coffee grain envelopes and leaves such as lettuce leaves or mint leaves.
- the fragments of one or more plants are chosen from fragments of calendula such as marigold, Lamiaceae such as lavender, Rosaceae such as rose, in particular damask rose, Asteraceae such as cornflower or jasmine, Mimosaceae such as prosopis, Centaureae, helichrysum, crocuses such as Crocus sativus, amaranth, camomile or peony, and mixtures thereof.
- the plant fragments according to the invention may be chosen from the leaves, flowers and petals of peony, marigold, lavender, damask rose, cornflower, jasmine, prosopis, and white and/or pink helichrysum.
- the substrate according to the invention may also directly comprise in its structure at least one cosmetic additive chosen in particular from: active agents, notably anticellulite, antiwrinkle, tanning, self-tanning, lightening, astringent, emollient, exfoliant, moisturizing, revitalizing or skin-protecting agents, fragrances, essential oils, surfactants, biosurfactants; colouring active agents and/or dyestuffs that are “activatable” in liquid medium, notably in solvent medium, such as aqueous medium; ingredients that are sensitive to moisture or sensitive in liquid medium, active agents that are unstable in aqueous medium, such as active agents that are sensitive to hydrolysis; active agents that are sensitive to acidic or basic pH; enzymes such as lipases, proteases, notably papain; phycocyanins such as spirulina, carotenoids, such as a-carotene and -carotene, vitamins such as vitamins A, D, E and K, riboflavin, pantothenic
- the substrate according to the invention contains less than 0.5% by weight, relative to the total weight of the substrate, preferably less than 0.2%, preferably less than 0.1% and preferably is free of at least one ingredient chosen from, and preferably is free of any ingredient chosen from: physical or chemical crosslinking agent, pH- regulating or pH-adjusting compound, basic compound, in particular with a pH in the range from 8 to 12, such as carbonate or bicarbonate, notably of calcium, sodium or potassium, NaOH, NH4OH, preserving agent, chelating agent, such as EDTA, polymer of synthetic origin, such as acrylic polymer, notably superabsorbent, Carbomer®, silicone, and mixtures thereof.
- the cosmetic substrate of the invention in solid and dry (anhydrous) form, proves to be particularly suitable for containing and protecting certain compounds that are only able to reveal their effect once the substrate has been placed in contact or impregnated with a suitable solvent medium, notably an aqueous medium.
- a suitable solvent medium notably an aqueous medium.
- These compounds, which are said to be “activatable” in or “sensitive” to a specific solvent medium may be, for example, active agents (hydrophilic or lipophilic), in particular hydrophilic active agents (which are sensitive or activatable in the presence of water), or alternatively certain pigments or dyes which only manifest their colouring effect when they are in the presence of a specific solvent medium.
- the substrate of the invention also makes it possible to exploit certain compounds, which are capable of affording advantageous properties, notably in terms of makeup effect and/or care effect, when they are used in or in contact with a certain solvent medium. They are generally referred to as compounds that are “sensitive” or “activatable” in a given solvent medium.
- the substrate according to the invention may prove to be advantageous with regard to the use, in its anhydrous structure, of hydrophilic active agents that are unstable in solvent medium.
- a hydrophilic active agent that may be used according to the invention may more particularly be a water-soluble or water-dispersible molecule, having cosmetic or dermatological activity.
- - free-radical scavengers and/or detoxifying agents such as ascorbic acid and derivatives thereof such as ascorbyl glucoside, also known as vitamin Cg, magnesium ascorbyl phosphate, cysteine derivatives, for instance N-acetylcysteine, proteins and enzymes, for example superoxide dismutase (SOD), peroxidases such as lactoperoxidase and lactoferrin, catalase, proteases such as subtilisin and papain, lipases, uricase, peptides and derivatives thereof, ubiquinone and cytochrome C,
- SOD superoxide dismutase
- - keratolytic agents such as a-hydroxy acids and a-keto acids, for instance salicylic acid and derivatives thereof, such as n-octanoyl-5-salicylic acid,
- - tanning accelerators such as tyrosine derivatives
- UV-screening agents such as screening agents bearing a sulfonic acid function, in particular 2-phenylbenzimidazole-5-sulfonic acid, sulisobenzone and benzene- 1 ,4-bis(3-methylidene-10-camphorsulfonic acid),
- moisturizers such as sorbitol, xylitol, urea and plant DNA
- optical brighteners such as stilbene derivatives and dyes such as the sodium salts of tartrazine,
- unstable cosmetic or dermatological hydrophilic active principles include ascorbic acid and salts thereof, in particular the sodium, potassium, magnesium or calcium salts.
- a C-glycoside derivative may make it possible to give a substrate according to the invention anti-ageing care properties, notably by exerting a skin-moisturizing and wrinkle-filling effect for a prolonged period over time.
- a C-glycoside derivative that is suitable for use in the invention may notably be obtained via the synthetic method described in WO 02/051 828.
- the salts of the C-glycoside derivatives that are suitable for use in the invention may comprise conventional physiologically acceptable salts of these compounds, such as those formed from organic or mineral acids. They may be linear, branched or cyclic aliphatic acids, or alternatively aromatic acids. These acids may also include one or more heteroatoms chosen from O and N, for example in the form of hydroxyl groups. Mention may notably be made of propionic acid, citric acid, tartaric acid, aspartic acid and glutamic acid.
- a C-glycoside derivative that is suitable for use in the invention may notably be hydroxypropyltetrahydropyrantriol, also known as C-p-D-xylopyranoside-2- hydroxypropane, sold notably as a solution at 30% by weight in a 60/40 (v/v) water/propylene glycol mixture under the trade name Mexoryl SBB®.
- HEPES or 4-(2-hydroxyethyl)piperazin-1 -ethanesulfonic acid is advantageously used as a desquamating agent. It exerts its effect notably by acting on the enzymes involved in desquamation or the degradation of corneodesmosomes, such as glycosidases or “stratum corneum chymotryptic enzyme” (SCCE). hydroxyalkylurea derivatives and also salts thereof and isomers thereof
- hydroxyalkylurea derivatives that are suitable for use in the invention, mention may be made of N-(2-hydroxyethyl)urea; N-(2-hydroxypropyl)urea; N-(3-hydroxypropyl)urea; N-(2,3-dihydroxypropyl)urea; N-(2,3,4,5,6-pentahydroxyhexyl)urea;
- N-methyl-N-(1,3,4,5,6-pentahydroxy-2-hexyl)urea N-methyl-N’-(1-hydroxy-2-methyl-2- propyl)urea; N-(1-hydroxy-2-methyl-2-propyl)urea; N-(1 ,3-dihydroxy-2-propyl)urea;
- N,N-bis(2-hydroxypropyl)urea N,N’-bis(2-hydroxypropyl)urea
- N,N-bis(2-hydroxyethyl)-N’-propylurea N,N-bis(2-hydroxypropyl)-N’-(2- hydroxyethyl)urea; N-tert-butyl-N’-(2-(hydroxyethyl)-N’-(2-(hydroxypropyl)urea; N-(1 ,3- dihydroxy-2-propyl)-N’-(2-hydroxyethyl)urea; N,N-bis(2-hydroxyethyl)-N’,N’- dimethylurea; N,N,N’,N’-tetrakis(2-hydroxyethyl)urea; N’,N’-bis(2-hydroxyethyl)-N’,N’- bis(2-hydroxypropyl)urea; and mixtures thereof.
- the hydroxyalkylurea derivative is N-(2-hydroxyethyl)urea.
- N-(2-hydroxyethyl)urea is also commercially available, in the form of a mixture at 50% by weight in water, from the company National Starch under the trade name Hydrovance.
- hydrophilic salicylic acid derivatives notably n-octanoyl-5-salicylic acid.
- Antiwrinkle active agents are also described in DE-A-2 703 185.
- N-(2-hydroxyethyl)urea is also commercially available, in the form of a mixture at 50% by weight in water, from the company National Starch under the trade name Hydrovance.
- hydrophilic salicylic acid derivatives notably n-octanoyl-5-salicylic acid.
- Antiwrinkle active agents notably n-octanoyl-5-salicylic acid.
- the substrate according to the invention may prove to be most particularly advantageous for the implementation of anti-wrinkle active agents, notably the C-glycoside derivatives as described previously, or adenosine or non-phosphate derivatives thereof.
- Adenosine is an active agent that is known for its anti-wrinkle activity, and is more particularly advantageous in the targeting of deep wrinkles. It is available in powder form, and may advantageously be formulated in solid compositions of compact powder type or “two-way cakes”.
- Adenosine has the particular feature of swelling when it is placed in contact with water.
- the substrate of the invention advantageously allows, for example if it comprises adenosine or a derivative thereof, on being moistened beforehand, the contact of this anti-wrinkle active agent extemporaneously, with water, thus allowing its activation during the application of the substrate to the skin, and leading to efficient filling of the wrinkles.
- anti-wrinkle active agents may be used according to the invention.
- Such an agent may be, for example, retinol, nicotinic acid and/or ubiquinone, or even other salicylic acid derivatives, such as n-octanoyl-5-salicylic acid.
- the dry substrate of the invention may allow the implementation of dyestuffs that are “sensitive” in or “activatable” with a specific solvent medium.
- activatable dyestuffs is intended, for example, to denote dyestuffs that can be activated to develop a certain colour, by placing them in contact with a specific solvent medium.
- the colouring effect of the dyestuffs is not perceptible in the anhydrous dry substrate.
- the substrate may notably have any shade in its packaging, for example white or grey, or any other colour associated with the colour of the other compounds present in its solid composition.
- the substrate When these dyestuffs are placed in contact with said solvent medium, dispersed and/or dissolved in this solvent medium, during the implementation of the cosmetic process using the substrate according to the invention, the substrate, once applied to the skin, reveals a colour, different from the colour which it had in its packaging before activation of the dyestuffs. This new colour advantageously matches the natural shade of the skin.
- This activation of the dyestuffs may also partly be exacerbated, for example by mechanical pressure exerted by the applicator at the time of application of the substrate to the keratin material, or by pH or temperature variations arising during the application of the composition to the skin.
- These dyestuffs may be chosen from water-soluble or water-insoluble organic or mineral pigments.
- DPPs diketopyrrolopyrroles
- mineral pigments that may be mentioned are titanium dioxide, optionally surface-treated, zirconium oxide or cerium oxide, and also zinc oxide, iron oxide (black, yellow or red) or chromium oxide, manganese violet, ultramarine blue, chromium hydrate and ferric blue, and metal powders, for instance aluminium powder and copper powder.
- the pigment is chosen from iron oxides, titanium oxide, ultramarine blue, and mixtures thereof.
- the pigments may have a size ranging from 35 to 200 pm and in particular from 40 to 100 pm. Pigments that are suitable for use in the invention may also have a size ranging from 0.05 to 34 pm, preferably from 0.1 to 25 pm, more particularly from 1 to 25 pm and preferably from 1 to 15 pm in diameter.
- the dyestuffs that are “activatable” with a specific solvent medium may be treated so as to give them sensitivity to said solvent medium.
- This treatment is generally a specific coating for making them soluble or dispersible in this solvent medium.
- the dyestuffs may be totally or partially surface-treated with a hydrophobic agent, to facilitate their dispersion in an oily solvent medium.
- the sensitive or activatable dyestuffs may represent from 0.1% to 50%, preferably from 1 % to 25% and more preferentially from 5% to 20% by weight relative to the total weight of the dry substrate according to the invention.
- the dry substrate according to the invention may comprise at least one dye.
- the dye may be hydrophilic or lipophilic.
- the hydrophilic or lipophilic dye(s) may represent from 0.001% to 10%, preferably from 0.05% to 5% or even from 0.01% to 1% by weight relative to the total weight of dry substrate according to the invention.
- the present invention is not at all limited to the embodiment variants described previously, but may implement any other may be termed “sensitive” to a specific solvent medium, in as much as they need to be placed in contact with a specific solvent medium, dispersed and/or dissolved in said solvent in order to be able to exploit them in terms of a colour effect.
- the nature of the solvent medium will be adapted to the nature of the dyestuff used and in particular to its hydrophilic/hydrophobic coating, and in particular so as to promote the revelation of its colour effect.
- the structure of the substrate according to the invention is advantageously obtained by cold dehydration (i.e. without heating), notably by freeze-drying, of a hydrogel formed by aqueous dispersion, for example of a powder, of said polysaccharides P1 , P2, each of said polysaccharides respectively representing a weight content within the range from 0.1% to 5%, preferably from 0.25% to 2%, preferably from 0.5% to 1.5%, preferably from 0.75% to 1.25%, relative to the total weight of the aqueous dispersion (P1+P2+water).
- the aqueous phase used for dispersing the polysaccharides and for forming a polysaccharide gel preferably comprises at least 65% water, preferably from 70% to 100% water, preferably from 80% to 100% water, preferably from 90% to 100%, relative to the total weight of aqueous phase.
- the water used may be sterile demineralized water and/or a floral water such as rose water, cornflower water, camomile water or lime blossom water, and/or a natural spring water or mineral water, for instance: Vittel water, Vichy basin water, Uriage water, Roche Posay water, Bourboule water, Enghien-les-Bains water, Saint Gervais-les- Bains water, Neris-les-Bains water, Allevar-les-Bains water, Digne water, Maizieres water, Neyrac-les-Bains water, Lons-le-Saunier water, Eaux Bonnes water, Rochefort water, Saint Christau water, Fumades water, Tercis-les-bains water and Avene water.
- the aqueous phase may also comprise reconstituted spring water, i.e. a water containing trace elements such as zinc, copper, magnesium, etc., reconstituting the characteristics of a spring water.
- the aqueous phase may also contain hydrophilic adjuvants, among which are polyols, such as glycerol; propanediol; glycols such as pentylene glycol, propylene glycol, butylene glycol, isoprene glycol, and polyethylene glycols such as PEG-8; sorbitol; sugars such as glucose, fructose, maltose, lactose and sucrose; and mixtures thereof.
- polyols such as glycerol
- propanediol glycols such as pentylene glycol, propylene glycol, butylene glycol, isoprene glycol, and polyethylene glycols such as PEG-8
- sorbitol sugars such as glucose, fructose, maltose, lactose and sucrose
- sugars such as glucose, fructose, maltose, lactose and sucrose
- Said polyol of the aqueous phase is water-miscible at room temperature (25°C) and may notably be chosen from polyols notably containing from 2 to 20 carbon atoms, preferably containing from 2 to 10 carbon atoms and preferentially containing from 2 to 6 carbon atoms, such as glycerol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol or diethylene glycol.
- polyols notably containing from 2 to 20 carbon atoms, preferably containing from 2 to 10 carbon atoms and preferentially containing from 2 to 6 carbon atoms, such as glycerol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol or diethylene glycol.
- the polyol that is water- miscible at room temperature may represent in the aqueous phase a content ranging from 0.1 % to 35% by weight, relative to the total weight of the composition, preferably ranging from 0.3% to 10% by weight, relative to the total weight of the aqueous phase.
- the aqueous phase may optionally also comprise a monoalcohol containing from 2 to 6 carbon atoms such as ethanol or isopropanol, notably in a content ranging from 0.01% to 10% by weight, relative to the total weight of aqueous phase, and preferably ranging from 1% to 7% by weight, relative to the total weight of the aqueous phase.
- the aqueous phase used for the manufacture of the non-crosslinked polysaccharide gel does not contain any monoalcohol.
- the aqueous phase may optionally also contain one (or more) water- soluble or water-insoluble cosmetic additive in suspension, as described above.
- the aqueous phase is homogenized at room temperature, preferably at a temperature within the range from 20 to 25°C, preferably at 25°C, to form a polysaccharide gel or hydrogel, said gel not being crosslinked, since this process does not use any crosslinking agent or any heating.
- the hydrogel thus obtained is preferably frozen, preferably at a temperature of between -100°C and 0°C, preferably between -80 and 0°C (limits exclusive), and preferably within the range from -80°C to -0.01 °C (limits inclusive here), preferably from -60°C to -4°C.
- the non-crosslinked polysaccharide hydrogel thus frozen is then dehydrated, preferably under vacuum, preferably at a pressure within the range from 1 Pa to 615 Pa, preferably by sublimation, notably by freeze-drying or else by zeodration, preferably by freeze-drying.
- the process for manufacturing the substrate according to the invention may also comprise at least one step of shaping, notably by moulding, preferably using at least one of the following processes: filling a mould, compressing, extruding, injecting, chopping, milling, grinding, rolling, stripping from the mould, and mixtures of these processes; said shaping step preferably taking place before or after a dehydration step, such as freeze-drying.
- the dry cosmetic substrate of the invention is thus obtained, without heating, without crosslinking, without requiring a strong base or an alkaline medium, and has a multicellular alveolar or multilayer microscopic structure, in which the open or closed cells or alvaeoli have a uniform size, forming a cohesive porous substrate of natural origin based on polysaccharides, which is a biomimetic of the cell wall of plants.
- This characteristic structure is the consequence of the following steps: a combination of specific polysaccharides, mild conditions of mixing (it is not necessary to heat) of these polysaccharides in an aqueous phase for the formation of a non-crosslinked gel, cooling, notably freezing, at ambient pressure followed by vacuum dehydration of the polysaccharide gel, preferably by sublimation.
- Said cooling (or freezing) of the non-crosslinked polysaccharide gel, followed by drying (or desiccation) of said frozen polysaccharide gel, by sublimation preferably corresponds to a freeze-drying process.
- the sublimed solvent is preferably essentially water, to more than 95% by weight relative to the weight of sublimed solvent. This freeze-drying may be performed according to conventional methods that are well known to those skilled in the art.
- zeodration dehydration using zeolites
- This technique is based on the use of vacuum, with an input of energy, to extract the water more rapidly from the gel in order to dehydrate it.
- a refrigeration system is not necessary since the water vapours are captured by the zeolites.
- a step of cooling, or even of freezing is preferably applied to the hydrogel, preferably before the zeodration.
- This substrate has the advantage of being both:
- the process for manufacturing a substrate according to the present invention is characterized in that it comprises the following steps:
- hydrogel comprising said at least two polysaccharides P1 and P2, and optionally at least one water-soluble or water-insoluble cosmetic additive in suspension
- - freezing the hydrogel preferably at a temperature in the range from -80°C to -0.01 °C, preferably from -60°C to -4°C,
- dry substrate means an anhydrous substrate, whose residual humidity, i.e. water content, is less than 5%, preferably less than 4%, preferably less than 3%, preferably less than 2%, and most particularly preferably is less than 1.5%, preferably less than 1%, preferably less than 0.7% by weight of water relative to the total weight of the substrate.
- composition of the gel and thus also of the dry substrate, to also contain a freeze-drying additive notably to facilitate the freeze-drying via the texturing of the non-crosslinked polysaccharide gel, but also the rehydration of the freeze-dried form (of the dry substrate), notably when the substrate is impregnated.
- a freeze-drying additive notably to facilitate the freeze-drying via the texturing of the non-crosslinked polysaccharide gel, but also the rehydration of the freeze-dried form (of the dry substrate), notably when the substrate is impregnated.
- freeze-drying additives examples include silica and derivatives thereof, clays, and also polymers of natural origin, xanthans, locust bean gum, guar gums, pectins, agar-agar, polymers of bacterial origin such as hyaluronic acid, dextran, gellan, which are particularly preferred as optional polysaccharides additional to the oligosaccharides P1 and P2, notably for this role as freeze-drying additive, if they are not already included in P1 , P2.
- the substrate according to the invention is advantageously free of physical or chemical crosslinking agent, of pH- regulating or pH-adjusting compound, notably of basic compound with a pH of between 8 and 12, or even between 9 and 12, such as carbonate, notably carbonate or bicarbonate, notably of calcium, sodium or potassium, NaOH, NH4OH, and mixtures thereof.
- pH- regulating or pH-adjusting compound notably of basic compound with a pH of between 8 and 12, or even between 9 and 12
- carbonate notably carbonate or bicarbonate, notably of calcium, sodium or potassium, NaOH, NH4OH, and mixtures thereof.
- this substrate also has the capacity for being multifunctional.
- cosmetic additives such as cosmetic active agents, notably active agents that are unstable in a conventional cosmetic formulation, for example: p-carotene, vitamin C or spirulina, which are then delivered, for example by moistening the substrate and/or applying the substrate to the skin.
- Said substrate according to the invention also has the capacity for dyeing hair or making up the skin with active agents, preferably natural active agents, added during the preparation of the substrate directly into the aqueous phase, before, notably during or after the formation of the gel described previously.
- polysaccharide-based means, for the dry substrate of the invention, a total polysaccharide content of at least 55% by weight, preferably within the range from 55% to 100% by weight, relative to the total weight of dry substrate.
- said polysaccharides P1 , P2 represent in total, in the composition of the dry substrate according to the invention, a content within the range from 60% to 100% by weight, relative to the total weight of the dry substrate, preferably from 65% to 100% by weight and better still from 70% to 100% by weight, or even 100% by weight, relative to the total weight of dry substrate representing 100%.
- the final dry substrate composition may have a weight content of from 0 to 45% of additives, relative to the weight of dry substrate.
- additives as a function of the type of drying used, in particular in the case of freezing, it may also prove advantageous to add a cryoprotective agent directed towards protecting the structure of the gel and then that of the dry substrate obtained.
- composition of the substrate according to the invention may thus comprise at least one cryoprotective agent that is compatible with cosmetic use, preferably chosen from: inositol, mannitol, glucose, sucrose, trehalose, maltose, xylitol, polyhydric alcohols, notably glycols or glycerol; amino acids, oligopeptides, cysteine, ascorbates, and mixtures thereof.
- cryoprotective agent that is compatible with cosmetic use, preferably chosen from: inositol, mannitol, glucose, sucrose, trehalose, maltose, xylitol, polyhydric alcohols, notably glycols or glycerol; amino acids, oligopeptides, cysteine, ascorbates, and mixtures thereof.
- the substrate according to the invention comprises at least one cosmetic additive chosen from active agents, notably anti-cellulite, anti- wrinkle, tanning, self-tanning, astringent, emollient, exfoliant, moisturizing, lightening, revitalizing and skin-protecting agents, fragrances, essential oils, surfactants, biosurfactants, and mixtures thereof.
- active agents notably anti-cellulite, anti- wrinkle, tanning, self-tanning, astringent, emollient, exfoliant, moisturizing, lightening, revitalizing and skin-protecting agents, fragrances, essential oils, surfactants, biosurfactants, and mixtures thereof.
- the substrate according to the invention comprises in its structure an active agent and/or a dyestuff that is “activatable” in liquid medium, notably in solvent medium, such as aqueous medium, at least one ingredient that is sensitive in liquid medium, notably chosen from active agents that are unstable in aqueous medium (hydrolysable), lycopenes, ⁇ -carotene, soapworts, notably obtained from plants, from dry nuts or from ivy, and mixtures thereof.
- solvent medium such as aqueous medium
- lycopenes e.g., ⁇ -carotene
- soapworts notably obtained from plants, from dry nuts or from ivy, and mixtures thereof.
- the dry substrate according to the invention does not require, and is thus advantageously free of, at least one of the following ingredients: preserving agent, chelating agent, such as EDTA, polymer of synthetic origin, such as acrylic polymer, notably superabsorbent, Carbomer®, silicone, and mixtures thereof.
- preserving agent such as EDTA
- chelating agent such as EDTA
- polymer of synthetic origin such as acrylic polymer, notably superabsorbent, Carbomer®, silicone, and mixtures thereof.
- the substrate of the invention advantageously provides a method for conserving active agents without an added preserving agent.
- the active agents are, for example, stabilized directly in the structure of the substrate, or alternatively in the cellulose matrix of plant part(s) in the case where P1 , P2 are provided by plant byproducts.
- the substrate according to the invention is, for example, in the form of a wipe, a sheet, a roll, a membrane, a mask, a disc, a pad, a cushion, a wad, solid or hollow beads, capsules, optionally encapsulating at least one cosmetic compound, pearls, pellets, a tablet, a sphere, a half-sphere, a cone, a pyramid, a core, a sponge or a foam, optionally comprising a textured surface, notably textured with undulations, inscriptions, pins, stepped angles, nesting volumes, and mixtures thereof; optionally comprising one or more parts that are detachable or splittable, respectively, as individual part(s), for example as single-dose squares, notably for single use; or having a form that is readily cuttable as a function of the amount of substrate desired for each respective single use.
- This type of dry substrate and of dry presentation form, and notably of freeze-dried product has the advantage(s) of being “carry-around”, i.e. readily transportable since it is of very reduced bulk, light, dry, readily available, easy to use and not posing any difficulties and/or constraints as regards storage.
- a subject of the present invention is also a cosmetic process for caring for, cleansing, removing makeup from and/or making up keratin materials, comprising at least one step consisting in applying a substrate according to the invention to the keratin materials, notably to the skin.
- the process also comprises at least one step, prior to the step of application to the keratin materials, consisting in at least partially impregnating said substrate and/or in taking up with the aid of said substrate: water, a cosmetic composition and/or a fragrance.
- the dry cosmetic substrates according to the invention may be used on all keratin materials such as the skin, the scalp, the hair, the eyelashes, the eyebrows, the nails or mucous membranes, notably in the form of a hygiene product, for example in the form of an article for cleansing the skin, mucous membranes and/or the hair or the beard, in particular in the form of an article for cleansing and/or removing makeup from the skin (of the face and/or the body), in the form of a mask or a patch, in the form of an exfoliant (also known as a desquamating or de-encrusting) wipe or pad or disc both for the face and for the body or for the hands, the exfoliant particles, as additives, preferably being already included within the structure of the dry substrate according to the invention.
- a hygiene product for example in the form of an article for cleansing the skin, mucous membranes and/or the hair or the beard, in particular in the form of an article for cleansing and/or removing makeup from the skin (of the face
- Another subject of the invention is a process for cleansing a keratin material, such as the skin, including the scalp, the hair, the eyelashes, the eyebrows, the nails or mucous membranes, comprising at least one step of applying a substrate as defined above to the keratin material and, where appropriate, at least one step of rinsing.
- a keratin material such as the skin, including the scalp, the hair, the eyelashes, the eyebrows, the nails or mucous membranes
- the gel composition to be freeze-dried is poured into a stainless-steel crystallizing dish (diameter 6.5 cm, height 2.2 cm) in a proportion of 30 g per crystallizing dish.
- the whole is placed in a lyophilizer and a person skilled in the art sets the freeze-drying parameters in the tests below:
- the final composition of the dry substrate is of the order of:
- Tests Cp2 to Cp6 are comparative tests.
- a crosslinked polysaccharide gel is manufactured with thermal physical and chemical crosslinking.
- the medium is very viscous, the calcium carbonate, at room temperature, does not enable crosslinking.
- Such a basic and/or thermal treatment leads to the formation of a non-cosmetic Pad, on account of insufficient sensory properties: rigid Pad, polystyrene noise, not soft, coarse.
- Example 1 non-crosslinked Ex. 1 according to the present invention, is the only substrate obtained which, simultaneously:
- This test is directed towards evaluating the cleansing power of the substrate on soiling formed from a mixture of charcoal particles and avocado oil, described in detail below, which is deposited on a skin model.
- the cleansing efficacy is assessed by visual observation of the state of the skin and the state of the cotton wad or dry substrate of the invention. This efficacy is characterized on a performance scale ranging from “+++++”, i.e. the state of the skin observed is clean and perfectly decent, to “+”, i.e. the state of the skin is not clean and soiling is still observed.
- An expert assesses whether the feel is more or less film-forming and if it has a moisturized effect (as opposed to a dehydrated effect) after the cleansing operation.
- the scoring is performed 3 minutes after applying the product. This perception is noted on a scale from +++++ (moisturized feel) to - (dehydrated feel).
- the Pad is more pleasant than the cotton wad, since it affords a filmforming effect and no dehydrating effect as obtained with the conventional commercial cotton wad.
- Each line of the table corresponds to a different substrate evaluation, performed using one or more polysaccharides P1 and P2, for which it is pointed out, respectively, whether it is a homopolysaccharide (“O”) or a heteropolysaccharide (“E”), and whether its weight-average molecular mass is h/m/l, with h for high molecular weight: hMw > 1 MDa (in the table, noted as h) m for medium molecular weight: 1 kDa ⁇ mMw ⁇ 1 MDa (in the table, noted as m)
- Cohesive substrate 0 (disintegrates totally) - 5 (cohesive substrate)
- the substrates with a polysaccharide composition in accordance with the invention are, simultaneously, alveolar (3), flexible in dry form (score of at least 3), soft (at least 2), cohesive (at least 2) and film-forming (1) during or
- Table 5 collates the average of the scores obtained for each substrate or Benchmark (commercial reference, referred to hereinbelow as “Bench”) with respect to each evaluated attribute.
- the foaming power is less than that with the wipe but greater than that for all the other Benches.
- the fresh effect is greater than that observed for the Benches, including Cotton wad + Aqua-source Biotherm in the case of Ex. 1 and 7.
- the “skin-tensioning” effect is greater for the three types of Pads tested according to the invention, whether or not they are pressed.
- the film-forming effect (protective or moisturizing) of the Pads of the invention comes just after that of the cotton wad + blue-jar Nivea cream in the case of Ex. 1 and 7, and is greater than that of the other cotton wad + water or wipe Benches for all the Pads according to the invention.
- Examples Ex. 13 to Ex. 26 of Table 6 below contain, in addition to the polysaccharides P1 and P2, at least one additive indicated as P3.
- the contents of each compound are indicated in dispersed form in water, as is the sum of the contents of P1 , P2, P3 in water, and the content of each compound in the final composition of the dry substrate.
- the sensory evaluation parameters of the Pads remain very good and compatible with cosmetic use of the Pads: in all cases, the dry substrate is flexible, soft, remains cohesive when it is partially impregnated with water, and deposits a film with a comfortable, fresh and moisturizing effect.
- the Pad is placed in 50 ml of TSB (stock solution: Trypticase soy broth)
- the cotton wad is massaging and then left for 5 minutes
- the stock solution is diluted tenfold in 9 ml of TSB (tenfold dilution) 2 x 0.5 ml of the stock solution and 2 x 0.5 ml of the tenfold dilution are deposited
- TSA Trypticase soy agar
- the stock solution is incubated at 32°C ⁇ 2°C for 24 hours (enrichment) and 0.5 ml is then subcultured and placed on TSA.
- the sample controlled shows low contamination (level ⁇ 50 cfu/g) with an unspecified microorganism.
- the Aw of the Pad of Ex. 1 is measured, in triplicate, bearing in mind that the Pad of Ex. 1 had been potentially handled several times (but not used) and stored in a hermetic box for six months before this Aw measurement.
- the results are collated in Table 8 below.
- a product may be considered as a medium that is not favourable for microbial growth if its Aw is less than or equal to 0.6.
- condition unfavorable for microbial growth Microbiologically stable Pad
- Aw > 0.6 condition favourable for microbial growth: antimicrobial protection of the Pad is to be envisaged (e.g. preserving agent).
- the dry substrate of the invention does not require any preserving agent.
- the Aloe vera leaves are obtained from the retail sector.
- the gel is recovered from the leaf and then washed three times with distilled water (removal of sensitizing agents, for example aloin).
- the mucilage of the gel is then ground coarsely with a hand mixer (Bosch MSM66110 ErgoMixx model, 600 W) until a fluid solution is obtained, and is then centrifuged at room temperature for 10 minutes at 10 000 rpm (Lynx 6000 model).
- the Aloe vera gel is separated from the insoluble fibres and used as polysaccharide mixing water.
- a dry extract of the gel obtained shows a concentration of dry compound of 1 % by weight, of which at least 50% of this dry extract is glucomannan with a weightaverage molecular mass of greater than 1000 g/mol (“m” or medium molecular weight).
- composition to be freeze-dried is poured into a stainless-steel crystallizing dish (diameter 6.5 cm, height 2.2 cm) in a proportion of 30 g per crystallizing dish.
- the whole is placed in a lyophilizer with the freeze-drying parameters set in the following manner: freezing temperature at -30°C, condenser temperature at -80°C, vacuum of about 0.025 mbar.
- a pad about 5.8 cm in diameter and 1 cm thick with a weight of about 0.6 g is obtained.
- the final composition of the substrate is of the order of:
- the cohesion of the substrate obtained after freeze-drying is compatible with cosmetic use.
- Comparative 31 shows that Aloe vera gel alone did not make it possible to obtain a cohesive substrate, notably when it is at least partially impregnated with water.
- the substrates according to the invention made from byproducts and comprising a combination of polysaccharides in accordance with the invention, the flexibility, softness, cohesion and film-forming effect properties obtained make it compatible with the desired cosmetic use.
- the lettuce leaves are obtained from a factory outlet (confidential contact).
- the banana skins are obtained from retail bananas.
- composition of the formulation before freeze-drying is a composition of the formulation before freeze-drying:
- Food byproduct e.g. lettuce or banana 0.6%
- the mixture is ground coarsely with a hand mixer (Bosch MSM66110 Ergomixx model, 600>) until a homogeneous dispersion which forms a hydrogel is obtained.
- the composition to be freeze-dried is poured into a stainless-steel crystallizing dish (diameter 6.5 cm, height 2.2 cm) in a proportion of 30 g per crystallizing dish. The whole is placed in a lyophilizer and the freeze-drying parameters set: freezing temperature -30°C, vacuum of 0.025 mbar.
- composition 1 A pad about 5.8 cm in diameter and 1 cm thick with a weight of about 0.6 g is obtained. After freeze-drying, the final composition is of the order of: Composition 1 :
- Composition 2 is a composition of Composition 2:
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cosmetics (AREA)
Abstract
La présente invention concerne un substrat cosmétique sec à base de polysaccharides, destiné au nettoyage, au démaquillage, au soin et/ou au maquillage de matières kératiniques, caractérisé en ce qu'il présente une structure microscopique alvéolaire formée par l'association non réticulée d'au moins deux polysaccharides spécifiques ; ainsi qu'un procédé cosmétique de soin, de nettoyage, de démaquillage et/ou de maquillage de matières kératiniques mettant en œuvre ce substrat.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FRFR2013003 | 2020-12-10 | ||
FR2013003A FR3117363A1 (fr) | 2020-12-10 | 2020-12-10 | Substrat cosmétique d’origine naturelle |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022123016A1 true WO2022123016A1 (fr) | 2022-06-16 |
Family
ID=74758987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2021/085209 WO2022123016A1 (fr) | 2020-12-10 | 2021-12-10 | Substrat cosmétique d'origine naturelle |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3117363A1 (fr) |
WO (1) | WO2022123016A1 (fr) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3301848A (en) | 1962-10-30 | 1967-01-31 | Pillsbury Co | Polysaccharides and methods for production thereof |
DE2703185A1 (de) | 1977-01-27 | 1978-08-10 | Henkel Kgaa | Kosmetische mittel mit einem gehalt an haut-feuchthaltemitteln |
WO2001002479A1 (fr) * | 1999-07-06 | 2001-01-11 | The Procter & Gamble Company | Systemes de feuilles auto-adhesives preformees adaptees a une application locale |
WO2001078678A1 (fr) * | 2000-04-12 | 2001-10-25 | The Procter & Gamble Company | Dispositifs preformes en forme de feuille adaptes a l'application topique |
WO2002051828A2 (fr) | 2000-12-22 | 2002-07-04 | L'oreal | Nouveau derives c-glycosides et utilisation |
EP1892015A2 (fr) * | 2006-08-10 | 2008-02-27 | L'Oréal | Film à dissolution améliorée et produit cosmétique le contenant |
US20200129416A1 (en) * | 2018-10-29 | 2020-04-30 | Tenart Biotech Limited | Facial cleansing tissue with natural plant origin and preparation method thereof |
CN111514034A (zh) * | 2020-05-27 | 2020-08-11 | 长沙蓝姿生物科技有限公司 | 一种具有保湿作用的卸妆干巾及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0542669B1 (fr) | 1991-11-04 | 1997-04-16 | Societe Nouvelle De Chimie Industrielle S.A. | Procédé pour la manufacture de pigments, spécialement de pigments fluorescents |
GB9418499D0 (en) | 1994-09-14 | 1994-11-02 | Ciba Geigy Ag | Process for producing n-methylated organic pigments |
DE59707889D1 (de) | 1996-01-30 | 2002-09-12 | Ciba Sc Holding Ag | Polymerisierbare Diketopyrrolopyrrole und damit hergestellte Polymere |
EP0787730B1 (fr) | 1996-01-30 | 2001-08-01 | Ciba SC Holding AG | Diketopyrrolopyrroles polyméisables et polymères préparés avec les-mêmes |
-
2020
- 2020-12-10 FR FR2013003A patent/FR3117363A1/fr active Pending
-
2021
- 2021-12-10 WO PCT/EP2021/085209 patent/WO2022123016A1/fr active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3301848A (en) | 1962-10-30 | 1967-01-31 | Pillsbury Co | Polysaccharides and methods for production thereof |
DE2703185A1 (de) | 1977-01-27 | 1978-08-10 | Henkel Kgaa | Kosmetische mittel mit einem gehalt an haut-feuchthaltemitteln |
WO2001002479A1 (fr) * | 1999-07-06 | 2001-01-11 | The Procter & Gamble Company | Systemes de feuilles auto-adhesives preformees adaptees a une application locale |
WO2001078678A1 (fr) * | 2000-04-12 | 2001-10-25 | The Procter & Gamble Company | Dispositifs preformes en forme de feuille adaptes a l'application topique |
WO2002051828A2 (fr) | 2000-12-22 | 2002-07-04 | L'oreal | Nouveau derives c-glycosides et utilisation |
EP1892015A2 (fr) * | 2006-08-10 | 2008-02-27 | L'Oréal | Film à dissolution améliorée et produit cosmétique le contenant |
US20200129416A1 (en) * | 2018-10-29 | 2020-04-30 | Tenart Biotech Limited | Facial cleansing tissue with natural plant origin and preparation method thereof |
CN111514034A (zh) * | 2020-05-27 | 2020-08-11 | 长沙蓝姿生物科技有限公司 | 一种具有保湿作用的卸妆干巾及其制备方法 |
Non-Patent Citations (6)
Title |
---|
COSMETICS AND TOILETRIES MAGAZINE, vol. 120, no. 9, 2005, pages 10 |
DATABASE GNPD [online] MINTEL; 11 January 2016 (2016-01-11), ANONYMOUS: "Korean Skincare Made Simple Starter Set", XP055846382, retrieved from https://www.gnpd.com/sinatra/recordpage/3713527/ Database accession no. 3713527 * |
E.A. MACGREGORC.T. GREENWOOD: "Handbook of Water-Soluble Gums and Resins", 1980, MCGRAW HILL BOOK COMPANY, pages: 240 - 328 |
KIRK-OTHMER, ENCYCLOPEDIA OF CHEMICAL TECHNOLOGY, vol. 3, 1982, pages 896 - 900 |
KIRK-OTHMER: "Encyclopedia of Chemical Technology", vol. 21, 1983, WILEY INTERSCIENCE, pages: 492 - 507 |
KLOAREG ET AL., OCEANOGRAPHY AND MARINE BIOLOGY, vol. 26, 1988, pages 259 - 315 |
Also Published As
Publication number | Publication date |
---|---|
FR3117363A1 (fr) | 2022-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1483299B1 (fr) | Derives de membranes cellulaires provenant de la biomasse et leur preparation | |
Spiridon et al. | Hemicelluloses: major sources, properties and applications | |
Kanlayavattanakul et al. | Biopolysaccharides for skin hydrating cosmetics | |
WO2020001069A1 (fr) | Kit de soins de la peau | |
Benabid et al. | Natural polymers: Cellulose, chitin, chitosan, gelatin, starch, carrageenan, xylan and dextran | |
WO2019047954A1 (fr) | Kit de soin de la peau | |
Chen et al. | Structure and properties of a (1→ 3)-β-d-glucan from ultrasound-degraded exopolysaccharides of a medicinal fungus | |
CN113194908B (zh) | 用于护理皮肤的套装 | |
Kabir et al. | Occurrence, distribution, and structure of natural polysaccharides | |
CN113194906B (zh) | 用于皮肤护理的试剂盒 | |
CN113226248A (zh) | 用于护理皮肤的套装 | |
Pei et al. | Oxidation of primary hydroxyl groups in chitooligomer by a laccase–TEMPO system and physico-chemical characterisation of oxidation products | |
Zhang et al. | Comprehensive review in moisture retention mechanism of polysaccharides from algae, plants, bacteria and fungus | |
CN114502599B (zh) | 一种超支化聚甘油多缩水甘油醚及其作为多糖交联剂的用途 | |
Elango et al. | Structural diversity, functional versatility and applications in industrial, environmental and biomedical sciences of polysaccharides and its derivatives–A review | |
WO2020133308A1 (fr) | Kit de soins de la peau | |
Giri et al. | Natural polysaccharides: Types, basic structure and suitability for forming hydrogels | |
WO2020181405A1 (fr) | Trousse pour le soin de la peau | |
WO2019185915A1 (fr) | Gel aqueux moussant comprenant un amidon modifié et un polysaccharide non amylacé | |
Lei et al. | Polysaccharides, microbial | |
Gruber | Polysaccharide-based polymers in cosmetics | |
WO2022123016A1 (fr) | Substrat cosmétique d'origine naturelle | |
Tunçer | Biopolysaccharides: properties and applications | |
EP1407759B1 (fr) | Composition cosmétique comprenant des acides hyaluronique et du chitosane | |
Panda et al. | Etherified polysaccharides in biomedical applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21823612 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21823612 Country of ref document: EP Kind code of ref document: A1 |